{
  "meta": {
    "title": "Mini_Test_4",
    "url": "https://brainandscalpel.vercel.app/mini-test-4-95cd821c.html",
    "scrapedAt": "2025-11-30T12:46:06.072Z"
  },
  "questions": [
    {
      "text": "A 45-year-old chronic kidney disease patient with diabetes is now prescribed DPP-4 inhibitors. Which of the following DPP-4 inhibitors is best suited for this patient?<div class='question-desc-html'><p>DPP-4 -&nbsp;dipeptidyl-peptidase-4</p></div>",
      "choices": [
        {
          "id": 1,
          "text": "Sitagliptin"
        },
        {
          "id": 2,
          "text": "Saxagliptin"
        },
        {
          "id": 3,
          "text": "Vildagliptin"
        },
        {
          "id": 4,
          "text": "Linagliptin"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p><strong>Linagliptin</strong>&nbsp;is preferred in this patient as it<strong> does not</strong>&nbsp;<strong>require dose adjustment</strong> in patients with renal failure.</p>\n<p><strong>Linagliptin</strong>&nbsp;is a&nbsp;<strong>dipeptidyl-peptidase-4&nbsp;</strong>(DPP-4)<strong>&nbsp;inhibitor</strong>. It is used in type 2 diabetes as monotherapy or in combination therapy when metformin is not tolerated or contraindicated. It&nbsp;binds extensively to plasma proteins and is cleared<strong>&nbsp;primarily by the hepatobiliary system.&nbsp;</strong>Hence, no dosage adjustment is needed in renal failure.</p>\n<p>Other DPP-4 inhibitors (sitagliptin, vildagliptin, saxagliptin, alogliptin) show renal elimination&nbsp;and therefore require dose reduction in renal failure.</p>\n<p><strong>Dipeptidyl peptidase-4 inhibitors&nbsp;</strong>enhance the release of insulin postprandially, decreases glucagon, and thereby lower mealtime as well as fasting glucose. They are weight neutral.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF6614",
      "difficulty": "medium"
    },
    {
      "text": "An elderly woman was hospitalized for pneumonia and is on antibiotic therapy with clindamycin. She now complains of diarrhea, abdominal pain, and fever. Her colonoscopy findings are shown in the image below. Which of the following toxins is most commonly associated with her GI symptoms?",
      "choices": [
        {
          "id": 1,
          "text": "Toxin A"
        },
        {
          "id": 2,
          "text": "Staphylococcal enterotoxins"
        },
        {
          "id": 3,
          "text": "Shiga toxin"
        },
        {
          "id": 4,
          "text": "Heat labile enterotoxin"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>The above clinical scenario along with the image given above showing yellow plaques and nodules on the mucosa are suggestive of <strong>pseudomembranous colitis</strong>. It is usually caused by <em><strong>Clostridium difficile</strong></em>. The pathogenesis is mediated by the enterotoxins -<strong> toxin A</strong> and toxin B.</p>\n<p><em>Clostridium difficile</em> is a gram-positive anaerobic bacillus that causes<strong>&nbsp;<em>Clostridioides </em>(formerly&nbsp;<em>Clostridium</em>)<em>&nbsp;</em><em>difficile</em> infection</strong>&nbsp;after ingestion of spores of the organism. The more severe form of the condition is known as <strong>pseudomembranous colitis</strong> (PMC).&nbsp;Enzyme immunoassay to detect <strong>glutamate dehydrogenase</strong> is<strong> less specific</strong> compared to<strong> toxin detection</strong> for diagnosis. So a combination of the two can be used for diagnostic confirmation.</p>\n<p>The condition is most commonly associated with&nbsp;<strong>prolonged antimicrobial use</strong>,&nbsp;which interferes with the commensal colonic microflora. The most commonly implicated antibiotics are&nbsp;cephalosporins,&nbsp;ampicillin, and <strong>clindamycin.</strong> The spores are spread by contact with the&nbsp;<strong>feces</strong>&nbsp;of affected individuals or asymptomatic carriers. It can persist on surfaces for months. Risk factors include&nbsp;<strong>poor hand hygiene</strong>, old age, and gastrointestinal surgery.</p>\n<p>The spores germinate in the small intestine and produce two toxins&mdash;<strong>toxin A</strong>&nbsp;(enterotoxin) and&nbsp;<strong>toxin B</strong>&nbsp;(cytotoxin). These interfere with the epithelial-cell barrier function and result in diarrhea and&nbsp;<strong>pseudomembrane</strong>&nbsp;formation. The pseudomembranes appear as small whitish-yellow plaques initially which later coalesce to involve the entire colon wall. It contains&nbsp;<strong>necrotic leukocytes</strong>,<strong>&nbsp;fibrin</strong>, and&nbsp;<strong>cellular debris</strong>. The<strong>&nbsp;anamnestic IgG response</strong>&nbsp;determines which patients develop the disease or remain asymptomatic.&nbsp;</p>\n<p>Symptoms include<strong>&nbsp;diarrhea</strong>, fever, and abdominal pain. The diagnosis is based on a combination of <strong>clinical criteria</strong> and detection of <strong>toxin</strong> or the <strong>organism</strong> in stool samples. This can be done by&nbsp;<strong>nucleic acid amplification testing</strong>&nbsp;(NAAT) methods such as&nbsp;<strong>polymerase chain reaction</strong>&nbsp;(PCR) or by&nbsp;<strong>culture</strong>.&nbsp;</p>\n<p><strong>Discontinuation</strong> of any ongoing antimicrobials and adequate hydration are general measures that are recommended.&nbsp;<strong>Oral fidaxomicin</strong>&nbsp;or&nbsp;<strong>vancomycin</strong>&nbsp;is the first-line treatment. Oral metronidazole can be used when these are not available.</p><hr><h3>Related Pearl: Diagnostic criteria for Clostridium difficile infection</h3><p>&nbsp;</p>\n<p>The diagnosis of CDI is based on a combination of clinical criteria:</p>\n<p>1.Diarrhea (&ge;3 unformed stools per 24 h for &ge;2 days) with no other recognized cause&nbsp; &nbsp; &nbsp;&nbsp;</p>\n<p>2.Detection of toxins A or B in the stool by PCR or culture</p>\n<p>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;or &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p>\n<p>&nbsp;Detection of pseudomembranes in the colon</p><hr><h3>Related Pearl: Mechanism of action of various bacterial toxins</h3><p>The mechanism of action of various bacterial toxins are as given below:</p>\n<p><span><strong>Increase in&nbsp;</strong></span><strong>cAMP</strong></p>\n<ul>\n<li>Bordetella pertusis</li>\n<li>Bacillus anthracis</li>\n<li>Vibrio cholerae - Cholera toxin</li>\n<li>Enterotoxigenic E.coli (ETEC) - heat labile toxin</li>\n</ul>\n<p><strong>Increase in cGMP</strong></p>\n<ul>\n<li>Enterotoxigenic E.coli (ETEC) - heat stable toxin</li>\n</ul>\n<p><strong>Inhibition of protein synthesis</strong></p>\n<ul>\n<li>Diptheria toxin: inhibit elongation factor-2 (EF-2)</li>\n<li>Pseudomonas: inhibit elongation factor-2 (EF-2)</li>\n<li>Clostridium difficile</li>\n<li>Enterohemorrhagic E.coli (EHEC)-Shiga-like toxin: inhibit 60S</li>\n<li>Shigella dysenteriae-&nbsp;Shiga toxin:&nbsp;inhibit 60S</li>\n</ul>",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/dffcb344ca434eddb0809c02d09b07a2.JPEG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MD6322",
      "difficulty": "medium"
    },
    {
      "text": "A young boy presents with pain in his fingers and toes. On examination, he had pallor and icterus. Electrophoresis shows increased HbA2, HbF, and S spike. Peripheral smear findings are given below.  What is the likely mode of inheritance of this condition?",
      "choices": [
        {
          "id": 1,
          "text": "X-linked recessive"
        },
        {
          "id": 2,
          "text": "Autosomal dominant"
        },
        {
          "id": 3,
          "text": "Autosomal recessive"
        },
        {
          "id": 4,
          "text": "X-linked dominant"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>The given scenario with electrophoresis showing increased <strong>HbA2, HbF,</strong> and<strong> S spike</strong> and peripheral smear showing <strong>sickle-shaped cells</strong> are suggestive of&nbsp;<strong>sickle cell disease</strong>. It is inherited in an <strong>autosomal recessive</strong> pattern.</p>\n<p>Sickle cell anemia is an <strong>autosomal recessive </strong>disorder that occurs due to the <strong>point mutation</strong> in the &beta;-globin gene which results in the replacement of glutamate residue with valine. This causes the production of <strong>sickle-shaped red blood cells</strong> due to the polymerization of <strong>deoxygenated</strong> <strong>hemoglobin (HbS).</strong></p>\n<p>Factors that predispose to sickling are infection, dehydration, and acidosis.</p>\n<p>The <strong>clinical features</strong> of sickle cell disease are due to the tendency of <strong>HbS molecules</strong> to <strong>stack</strong> into <strong>polymers</strong> when <strong>deoxygenated.</strong> The features are:</p>\n<ul>\n<li>Moderately severe hemolytic anemia with jaundice.</li>\n<li><strong>Painful bone crisis-</strong>&nbsp;hand-foot syndrome or dactylitis of the bones of hands and feet.</li>\n<li><strong>Acute chest syndrome</strong> typically presents with fever, cough, chest pain, and <strong>pulmonary infiltrates</strong>.</li>\n<li>Hyposthenuria- inability to concentrate urine.</li>\n<li>The<strong> aplastic crisis</strong> stems from the infection of red cell progenitors by <em>parvovirus B19</em>, which causes a transient cessation of erythropoiesis and a sudden worsening of the anemia.</li>\n<li>Spleen\n<ul>\n<li>In children-&nbsp;<strong>splenic sequestration</strong> crises occur which results in <strong>splenomegaly</strong> due to red pulp congestion.</li>\n<li>Adolescence or early adulthood-&nbsp;<strong>autosplenectomy</strong> occurs due to splenic infarction, fibrosis, and progressive shrinkage.</li>\n<li>Increased susceptibility to infection with encapsulated organisms like pneumococcal, meningococcal, and <em>Haemophilus influenza</em> septicemia, but can be reduced by vaccination and prophylactic antibiotics.</li>\n</ul>\n</li>\n<li>Other clinical features- priapism, leg ulcers, <strong>stroke</strong>, retinopathy, pigment gallstones, and growth retardation.</li>\n</ul>\n<p>The diagnosis is suggested by the clinical findings, the presence of irreversibly sickled red cells on the peripheral smear, and hemoglobin electrophoresis&nbsp;showing<strong> increased HbA2, HbF,</strong> and <strong>S spike</strong>. The changes in the skull resemble a <strong>crewcut</strong> in radiographic studies&nbsp;as a result of compensatory erythroid hyperplasia.</p>\n<p>The image given below shows the sickling of RBCs in sickle cell disease.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/eb3825393aff4017bd812141e8d3ec77x1280x960.JPEG\" alt=\"Explanation Image\"><p>The image given below shows Howell-Jolly bodies seen in asplenia.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/2d6c82c1ef6a49469bd89681e8a61d7dx610x600.PNG\" alt=\"Explanation Image\"><p>Note: The sickle cell trait protects against <strong>falciparum malaria</strong> in certain African populations.</p><hr><h3>Related Pearl: Structural Alterations of the β -Globin Gene</h3><table>\n<tbody>\n<tr>\n<td>\n<p>Alteration</p>\n</td>\n<td>\n<p>Function affected</p>\n</td>\n<td>\n<p>Disease</p>\n</td>\n</tr>\n<tr>\n<td rowspan=\"4\">\n<p>Point Mutation</p>\n</td>\n<td>\n<p>Protein folding</p>\n</td>\n<td>\n<p>Sickle cell disease</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Transcriptional control</p>\n</td>\n<td>\n<p>&beta;-Thalassemia</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Frameshift &amp; nonsense mutations</p>\n</td>\n<td>\n<p>&beta;-Thalassemia</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>RNA processing</p>\n</td>\n<td>\n<p>&beta;-Thalassemia</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Deletion</p>\n</td>\n<td>\n<p>mRNA production</p>\n</td>\n<td>\n<p>&beta;<sup>0</sup>-Thalassemia</p>\n<p>Hemoglobin Lepore</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Rearrangement</p>\n</td>\n<td>\n<p>mRNA production</p>\n</td>\n<td>\n<p>&beta;-Thalassemia type III</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div><hr><h3>Related Pearl: Inheritance pattern of important diseases</h3><table class=\"t1\">\n<tbody>\n<tr>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\"><span><strong>Autosomal dominant</strong></span></div>\n</td>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\"><span><strong>Autosomal recessive</strong></span></div>\n</td>\n</tr>\n<tr>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\"><span><strong>HEAV</strong>y<strong> DOMINANT</strong></span></div>\n</td>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\"><span><strong>ABC DEF GHI</strong></span></div>\n</td>\n</tr>\n<tr>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\"><span><strong>H</strong>: <strong>H</strong>ereditary spherocytosis, <strong>H</strong>ypercholesterolemia,&nbsp;<strong>H</strong>ypertrophic obstructive cardiomyopathy,&nbsp; <strong>H</strong>untington&rsquo;s disease</span></div>\n</td>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\">\n<div class=\"p1\"><span><strong>A</strong>: <strong>A</strong>taxia-telangiectasia,&nbsp;<strong>A</strong>lbinism, <strong>A</strong>lkaptonuria,&nbsp;</span></div>\n</div>\n<div class=\"p1\"><span><strong>A</strong>utosomal-recessive polycystic kidney disease</span></div>\n</td>\n</tr>\n<tr>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\"><span><strong>E</strong>: <strong>E</strong>hler-Danlos syndrome</span></div>\n</td>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\"><span><strong>B</strong>: <strong>B</strong>lood disorders like&nbsp;<strong>b</strong>eta-thalassemia and sickle-cell anemia</span></div>\n</td>\n</tr>\n<tr>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\"><span><strong>A</strong>: <strong>A</strong>chondroplasia</span></div>\n</td>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\">\n<div class=\"p1\"><span><strong>C</strong>: <strong>C</strong>ystic fibrosis,&nbsp;</span></div>\n</div>\n<div class=\"p1\"><span><strong>C</strong>ongenital adrenal hyperplasia</span></div>\n</td>\n</tr>\n<tr>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\"><span><strong>V</strong>: <strong>V</strong>on Willebrand disease, Von Hippel Lindau disease</span></div>\n</td>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\"><span><strong>D</strong>: Sensorineural <strong>d</strong>eafness</span></div>\n</td>\n</tr>\n<tr>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\"><span><strong>D</strong>: <strong>D</strong>ystrophia myotonica</span></div>\n</td>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\">\n<div class=\"p1\"><span><strong>E</strong>: <strong>E</strong>mphysema&nbsp;</span></div>\n</div>\n<div class=\"p1\"><span>(alpha1- antitrypsin deficiency)</span></div>\n</td>\n</tr>\n<tr>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\"><span><strong>O</strong>: <strong>O</strong>steogenesis imperfecta,&nbsp;<strong>O</strong>tosclerosis (variable)</span></div>\n</td>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\"><span><strong>F</strong>: <strong>F</strong>riedrich ataxia</span></div>\n</td>\n</tr>\n<tr>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\"><span><strong>M</strong>: <strong>M</strong>arfans syndrome, Multiple endocrine neoplasias (MEN)</span></div>\n</td>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\"><span><strong>G</strong>: <strong>G</strong>aucher&rsquo;s disease, <strong>G</strong>alactosemia, glycogen storage diseases</span></div>\n</td>\n</tr>\n<tr>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\"><span><strong>I</strong>: <strong>I</strong>ntermittent porphyria</span></div>\n</td>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\"><span><strong>H</strong>: <strong>H</strong>omocystinuria, <strong>H</strong>emochromatosis</span></div>\n</td>\n</tr>\n<tr>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\"><span><strong>N</strong>: <strong>N</strong>eurofibromatosis 1 and 2</span></div>\n</td>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\"><span><strong>I</strong>: <strong>I</strong>nborn errors of metabolism- Phenylketonuria, lysosomal storage diseases</span></div>\n</td>\n</tr>\n<tr>\n<td class=\"td1\" valign=\"top\"><span><strong>A</strong>: <strong>A</strong>utosomal-dominant polycystic kidney disease</span></td>\n<td class=\"td1\" valign=\"top\">Other conditions: Wilson's disease, sickle cell anemia, thalassemias, spinal muscular atrophy, Kartagener syndrome,&nbsp;</td>\n</tr>\n<tr>\n<td class=\"td1\" valign=\"top\"><span><strong>N</strong>: <strong>N</strong>oonan's syndrome</span></td>\n<td class=\"td1\" valign=\"top\">Mucopolysaccharidoses (except Hunter syndrome)</td>\n</tr>\n<tr>\n<td class=\"td1\" valign=\"top\"><span><strong>T</strong>: <strong>T</strong>uberous sclerosis</span></td>\n<td class=\"td1\" valign=\"top\">Sphingolipidoses (except Fabry disease)</td>\n</tr>\n<tr>\n<td class=\"td1\" valign=\"top\"><span>Other conditions:<strong>&nbsp;</strong>Familial adenomatous polyposis, Hereditary hemorrhagic telangiectasia, Li-Fraumeni syndrome, Pseudohypoparathyroidism</span></td>\n<td class=\"td1\" valign=\"top\">&nbsp;</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>&nbsp;</p><table class=\"t1\">\n<tbody>\n<tr>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\"><span><strong>X-linked recessive</strong></span></div>\n</td>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\"><span><strong>X-linked dominant</strong></span></div>\n</td>\n</tr>\n<tr>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\"><span><strong>Lady Hardinge College Girls Don&rsquo;t Care About Foolish Words</strong></span></div>\n</td>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\"><span><strong>Red Rose </strong>for<strong> All Children</strong></span></div>\n</td>\n</tr>\n<tr>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\">\n<div class=\"p1\"><span>(<strong>L</strong>ady) <strong>L</strong>esch&ndash;Nyhan syndrome,&nbsp;<strong>L</strong>owe syndrome</span></div>\n</div>\n</td>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\"><span>(<strong>R</strong>ed) <strong>R</strong>ett&rsquo;s syndrome</span></div>\n</td>\n</tr>\n<tr>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\"><span>(<strong>H</strong>ardinge) <strong>H</strong>unter's syndrome, <strong>H</strong>emophilia A and B</span></div>\n</td>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\"><span>(<strong>R</strong>ose) <strong>R</strong>ickets</span></div>\n</td>\n</tr>\n<tr>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\"><span>(<strong>C</strong>ollege) <strong>C</strong>hronic granulomatous disease</span></div>\n</td>\n<td class=\"td1\" valign=\"top\">\n<div><span>(<strong>A</strong>ll) <strong>A</strong>lport syndrome&nbsp;(common inheritance pattern)</span></div>\n</td>\n</tr>\n<tr>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\"><span>(<strong>G</strong>irls) <strong>G</strong>-6-PD deficiency</span></div>\n</td>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\"><span>(<strong>C</strong>hildren) Type X <strong>C</strong>harcot&ndash;Marie&ndash;Tooth disease</span></div>\n</td>\n</tr>\n<tr>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\"><span>(<strong>D</strong>on&rsquo;t) <strong>D</strong>uchenne muscular dystrophy, <strong>D</strong>iabetes insipidus</span></div>\n</td>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\">&nbsp;</div>\n</td>\n</tr>\n<tr>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\"><span>(<strong>C</strong>are) <strong>C</strong>olor blindness</span></div>\n</td>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p2\">&nbsp;</div>\n</td>\n</tr>\n<tr>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\">\n<div class=\"p1\"><span>(<strong>A</strong>bout) <strong>A</strong>gammaglobulinemia,&nbsp;<strong>A</strong>lport syndrome, Ocular&nbsp;<strong>a</strong>lbinism</span></div>\n</div>\n</td>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p2\">&nbsp;</div>\n</td>\n</tr>\n<tr>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\"><span>(Foolish)&nbsp;<strong>F</strong>abry disease</span></div>\n</td>\n<td class=\"td1\" valign=\"top\">&nbsp;</td>\n</tr>\n<tr>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\"><span>(<strong>W</strong>ords) <strong>W</strong>iskott&ndash;Aldrich syndrome</span></div>\n</td>\n<td class=\"td1\" valign=\"top\">&nbsp;</td>\n</tr>\n<tr>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\">\n<div class=\"p1\"><span>Other conditions: Menke's disease,&nbsp;</span>Ornithine transcarbamylase deficiency</div>\n</div>\n</td>\n<td class=\"td1\" valign=\"top\">&nbsp;</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p><span>&nbsp;</span></p><hr><h3>Related Pearl: Pathological Named Bodies</h3><table>\n<tbody>\n<tr>\n<td><strong>Bodies</strong></td>\n<td><strong>Found in</strong></td>\n</tr>\n<tr>\n<td>Asteroid bodies</td>\n<td>Sarcoidosis, Sporotrichosis</td>\n</tr>\n<tr>\n<td>\n<p>Halberstaedter&ndash;Prowazek bodies</p>\n</td>\n<td>Trachoma&nbsp;</td>\n</tr>\n<tr>\n<td>Miyagawa bodies</td>\n<td>Lymphogranuloma venereum&nbsp;</td>\n</tr>\n<tr>\n<td>Levinthal&ndash;Cole&ndash;Lillie bodies</td>\n<td>Psittacosis</td>\n</tr>\n<tr>\n<td>Leishman&ndash;Donovan bodies</td>\n<td>Kala-azar&nbsp;</td>\n</tr>\n<tr>\n<td>Negri bodies</td>\n<td>Rabies</td>\n</tr>\n<tr>\n<td>Guarnieri bodies</td>\n<td>Vaccinia</td>\n</tr>\n<tr>\n<td>Bollinger bodies</td>\n<td>Fowl pox</td>\n</tr>\n<tr>\n<td>Henderson&ndash;Paterson bodies</td>\n<td>Molluscum contagiosum&nbsp;</td>\n</tr>\n<tr>\n<td>Cowdry type-A bodies</td>\n<td>Yellow fever, Herpes virus infection&nbsp;</td>\n</tr>\n<tr>\n<td>Cowdry type-B bodies</td>\n<td>Adenovirus, poliovirus</td>\n</tr>\n<tr>\n<td>Rusell bodies</td>\n<td>Multiple myeloma&nbsp;</td>\n</tr>\n<tr>\n<td>Aschoff bodies</td>\n<td>Rheumatic fever&nbsp;</td>\n</tr>\n<tr>\n<td>Call&ndash;Exner bodies</td>\n<td>Granulosa cell tumor of the&nbsp;ovary&nbsp;</td>\n</tr>\n<tr>\n<td>Civatte (colloid) bodies</td>\n<td>Lichen planus&nbsp;</td>\n</tr>\n<tr>\n<td>Michaelis&ndash;Gutmann bodies</td>\n<td>Malakoplakia&nbsp;</td>\n</tr>\n<tr>\n<td>Lewy bodies</td>\n<td>Parkinson's disease&nbsp;</td>\n</tr>\n<tr>\n<td>Pappenheimer bodies</td>\n<td>Non-heme iron pigments in siderocytes&nbsp;</td>\n</tr>\n<tr>\n<td>Howell&ndash;Jolly bodies</td>\n<td>Splenectomy, Megaloblastic Anemia, Hemolytic anemia&nbsp;</td>\n</tr>\n<tr>\n<td>Heinz bodies</td>\n<td>G-6-PD deficiency&nbsp;</td>\n</tr>\n<tr>\n<td>Gamna&ndash;Gandy bodies</td>\n<td>Congestive splenomegaly&nbsp;</td>\n</tr>\n<tr>\n<td>Mallory bodies</td>\n<td>Hyaline inclusions in hepatocytes seen in alcoholic cirrhosis, Indian childhood cirrhosis</td>\n</tr>\n<tr>\n<td>Councilman bodies</td>\n<td>Hepatocytes undergoing apoptosis,&nbsp;seen mainly in acute viral hepatitis.</td>\n</tr>\n<tr>\n<td>Psammoma bodies</td>\n<td>Dystrophic calcification in meningioma, papillary serous cystadenoma of ovary &amp; papillary carcinoma of thyroid, papillary type of renal cell carcinoma.</td>\n</tr>\n<tr>\n<td>Donovan bodies</td>\n<td>Granuloma inguinale&nbsp;</td>\n</tr>\n<tr>\n<td>Nissl's bodies</td>\n<td>Cytoplasmic inclusions in neurons&nbsp;</td>\n</tr>\n<tr>\n<td>Mooser bodies</td>\n<td>Typhus fever</td>\n</tr>\n<tr>\n<td>Creola bodies</td>\n<td>Asthma&nbsp;</td>\n</tr>\n<tr>\n<td>Verocay bodies</td>\n<td>Schwannoma&nbsp;</td>\n</tr>\n<tr>\n<td>Schiller&ndash;Duval bodies</td>\n<td>Endodermal sinus tumor&nbsp;</td>\n</tr>\n<tr>\n<td>\n<p>Hirano bodies</p>\n</td>\n<td>&nbsp;Alzheimer&rsquo;s disease</td>\n</tr>\n<tr>\n<td>\n<p>Ferruginous bodies</p>\n</td>\n<td>Asbestosis&nbsp;</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/a867618ef8514df1909cbb2eaa7450f2.JPEG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF6611",
      "difficulty": "easy"
    },
    {
      "text": "A young man with type 1 diabetes mellitus is brought with severe nausea, vomiting, and abdominal pain. A bolus of both normal saline and IV short-acting insulin is administered. What is the next step in management?<div class='question-desc-html'><p>Random blood sugar: 500mg/dl<br />Urine ketones ++<br />Serum potassium - 5.4mEq/L</p></div>",
      "choices": [
        {
          "id": 1,
          "text": "Start normal saline infusion and continuous insulin infusion"
        },
        {
          "id": 2,
          "text": "Administer potassium at 10 mEq/ hour"
        },
        {
          "id": 3,
          "text": "Administer bicarbonate 50 mEq in sterile water"
        },
        {
          "id": 4,
          "text": "Start continuous insulin infusion and administer potassium"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>The given clinical scenario is suggestive of <strong>diabetic ketoacidosis</strong> (DKA). The next step in management is to <strong>start</strong> <strong>normal saline infusion </strong>and<strong> continuous insulin infusion</strong>.</p>\n<p>DKA is a complication of <strong>poorly controlled</strong> diabetes mellitus common in <strong>type 1 diabetes mellitus</strong> but can also occur in type 2. It occurs in the setting of absolute or relative <strong>insulin deficiency</strong> along with <strong>glucagon excess</strong> leading to extreme hyperglycemia.</p>\n<p>Clinical features include severe <strong>nausea</strong>, <strong>vomiting</strong>, severe <strong>abdominal pain, </strong>and severe <strong>volume depletion. </strong>Signs include Kussmaul breathing, fruity odor on the patient’s breath, tachycardia, <strong>dehydration,</strong> and <strong>hypotension. </strong></p>\n<p>The diagnosis of <strong>DKA</strong> is made based on the following parameters:</p>\n<ul>\n<li><strong>Hyperglycemia</strong> &gt;250 mg/dL</li>\n<li><strong>Ketosis</strong> or <strong>ketones</strong> in the <strong>urine</strong></li>\n<li><strong>Metabolic acidosis</strong> with <strong>pH &lt;7.4</strong> and <strong>HCO<sub>3</sub> &lt;15</strong> mEq/L</li>\n<li><strong>High anion gap</strong> due to ketoacids and lactic acidosis</li>\n</ul>\n<p><strong>Pseudohyponatremia </strong>(dilutional) is seen as a result of <strong>hyperglycemia </strong>due to osmotic shift. <strong>Normal sodium levels</strong> on admission indicate <strong>severe dehydration</strong>. <strong>Potassium</strong> levels at presentation may be <strong>normal</strong> or <strong>elevated</strong> despite total body deficit, due to intracellular shift. If the initial serum <strong>potassium</strong> <strong>&lt;3.3 mEq/L</strong>, insulin should be administered only after the <strong>correction </strong>of hypokalemia. This is because treatment with <strong>insulin</strong> and fluids can <strong>worsen hypokalemia</strong>.</p>\n<p>The mainstay management of diabetic ketoacidosis includes urgent <strong>fluid resuscitation</strong> and maintenance, along with<strong> insulin therapy</strong>, electrolyte replacement, and supportive care. The algorithm of management is given below. </p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/3bd9e1e7228e4ca0bf552de377af0dcax1280x2847.JPEG\" alt=\"Explanation Image\"><div id=\"article-74978.s8\">Criteria for <strong>resolution</strong> of ketoacidosis include:</div>\n<ul>\n<li>Blood glucose &lt;200 mg/dL, and</li>\n<li>Two of the following criteria:\n<ul>\n<li>Serum bicarbonate level ≥15 mEq/L</li>\n<li>Venous pH &gt;7.3</li>\n<li>Anion gap ≤12 mEq/L</li>\n</ul>\n</li>\n</ul><hr><h3>Related Pearl: Comparative Features of Diabetic Ketoacidosis and Hyperglycemic Hyperosmolar State</h3><table>\n<tbody>\n<tr>\n<td>\n<p><strong>&nbsp;</strong></p>\n</td>\n<td>\n<p><strong>DKA</strong></p>\n</td>\n<td>\n<p><strong>HHS</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Seen in </strong></p>\n</td>\n<td>\n<p>Type 1 DM</p>\n</td>\n<td>\n<p>Type 2 DM</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Clinical features</strong></p>\n</td>\n<td>\n<p>Abdominal pain</p>\n<p>Kussmaul respiration</p>\n<p>Fruity odour of breath</p>\n</td>\n<td>\n<p>Altered sensorium</p>\n<p>Coma</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Glucose (mg/dL)</strong></p>\n</td>\n<td>\n<p>250&ndash;600</p>\n</td>\n<td>\n<p>600&ndash;1200</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Sodium</strong></p>\n</td>\n<td>\n<p>120&ndash;125</p>\n</td>\n<td>\n<p>135&ndash;145</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Osmolality </strong></p>\n</td>\n<td>\n<p>300&ndash;320</p>\n</td>\n<td>\n<p>330&ndash;380</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Plasma Ketones</strong></p>\n</td>\n<td>\n<p>++++</p>\n</td>\n<td>\n<p>+/-</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Serum Bicarbonate</strong></p>\n</td>\n<td>\n<p>&lt; 15 meq/ L</p>\n</td>\n<td>\n<p>Normal to slightly &darr;</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Arterial pH </strong></p>\n</td>\n<td>\n<p>6.8&ndash;7.3</p>\n</td>\n<td>\n<p>&gt;7.3</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Arterial pCO<sub>2 </sub>(mmHg)</strong></p>\n</td>\n<td>\n<p>20&ndash;30</p>\n</td>\n<td>\n<p>Normal</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Anion Gap</strong></p>\n</td>\n<td>\n<p><strong>&uarr;</strong></p>\n</td>\n<td>\n<p>Normal to slightly &uarr;</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF1925",
      "difficulty": "medium"
    },
    {
      "text": "A 50-year-old man presents with symptoms of fatigue and headache. On further examination, he is found to have pallor, tingling, and numbness over his extremities. Peripheral smear shows macrocytic anemia. Laboratory findings revealed methylmalonic acid excretion in the urine. He was diagnosed with type 2 diabetes 15 years ago and has been taking metformin. Which of the following is most likely deficient in him?",
      "choices": [
        {
          "id": 1,
          "text": "Vitamin B9"
        },
        {
          "id": 2,
          "text": "Vitamin B12"
        },
        {
          "id": 3,
          "text": "Vitamin B6"
        },
        {
          "id": 4,
          "text": "Vitamin B1"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>A <strong>vitamin B12</strong>/ cobalamin deficiency is most likely seen in him.</p>\n<p>The given clinical&nbsp;features of&nbsp;<strong>peripheral neuropathy</strong>, peripheral smear finding of&nbsp;<strong>macrocytic anemia</strong>&nbsp;with&nbsp;<strong>hypersegmented neutrophils, methylmalonic acid excretion</strong> in the urine,<strong>&nbsp;</strong>and history of <strong>metformin</strong> intake after being diagnosed with type 2 diabetes mellitus indicate a <strong>vitamin B12&nbsp;deficiency.<br /></strong></p>\n<p>Vitamin B12 or cobalamin is a water-soluble vitamin that is derived from animal products such as red meat, dairy, and eggs. Its absorption in the <strong>terminal ileum</strong> is facilitated by the presence of&nbsp;<strong>intrinsic factor</strong>, produced by parietal cells in the stomach. There are two vitamin B<sub>12</sub>-dependent enzymes:</p>\n<ul>\n<li><strong>Methionine synthase</strong>&nbsp;(homocysteine methyltransferase): Catalyzes the conversion of homocysteine to methionine.</li>\n<li><strong>Methylmalonyl CoA mutase</strong>: methylmalonyl CoA, formed as an intermediate in the catabolism of valine, isoleucine, and propionyl CoA is converted to succinyl CoA.</li>\n</ul>\n<p>The activity of methylmalonyl CoA mutase is greatly reduced in vitamin B12 deficiency, leading to an accumulation of <strong>methylmalonic acid</strong> and its <strong>excretion in urine</strong>. Since vitamin B12 is also linked to the regeneration of methionine from homocysteine, its deficiency can result in&nbsp;<strong>hyperhomocysteinemia</strong>&nbsp;as well.</p>\n<p>Risk factors for B12 deficiency include gastric atrophy (<strong>pernicious anemia</strong>), terminal ileal disease, strict vegetarianism, acid-reducing drugs (e.g., H2 blockers), and&nbsp;prolonged use of <strong>metformin</strong>.&nbsp;The interference by metformin on calcium-dependent membrane action is responsible for vitamin B12-intrinsic factor malabsorption in the terminal ileum.</p>\n<p>On examination, patients present <strong>anemia</strong>, fatigue, and pallor symptoms. Other presenting complaints may include <strong>peripheral neuropathy</strong>, <strong>glossitis</strong>, diarrhea, headaches, neuropsychiatric disturbances like&nbsp;dementia, and <strong>subacute combined degeneration of spinal cord&nbsp;</strong>(<strong>SACD</strong>) leading to&nbsp;<strong class=\"ng-binding\">ataxia</strong>. A peripheral smear shows <strong>macrocytic anemia</strong> and <strong>hypersegmented neutrophils</strong>.</p>\n<p>Other options:</p>\n<p>Option A: <strong>Vitamin B9&nbsp;</strong>(Folic acid) deficiency can also be seen in patients on&nbsp;prolonged use of <strong>metformin&nbsp;</strong>and&nbsp;can cause&nbsp;<strong>macrocytic anemia</strong>. Urinary excretion of <strong>methylmalonic acid</strong> differentiates between megaloblastic anemia&nbsp;due to folate and vitamin B<sub>12</sub>&nbsp;deficiency. Folate deficiency results in:</p>\n<ul>\n<li>Megaloblastic anemia&nbsp;</li>\n<li>Homocystenemia</li>\n<li>Neural tube defects&nbsp;(spina bifida, Anencephaly) in the fetus.</li>\n</ul>\n<p>Option C: A patient with pyridoxine/ <strong>Vitamin B6</strong> deficiency presents with symptoms of seborrhea, glossitis, convulsions, neuropathy, depression, confusion, and <strong>microcytic anemia</strong>.</p>\n<p>Option D: A patient with thiamine/ <strong>Vitamin B1</strong> deficiency presents either <strong>dry Beriberi</strong> with <strong>predominantly neurological</strong> symptoms like <strong>neuropathy</strong>, muscle weakness and wasting or <strong>wet Beriberi</strong> with predominant cardiac symptoms like cardiomegaly, tachycardia, high output congestive cardiac failure.</p><hr><h3>Related Pearl: Vitamin Deficiency States (Water-soluble Vitamins)</h3><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Vitamin</strong></p>\n</td>\n<td>\n<p><strong>Deficiency State</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Thiamine (<strong>B<sub>1</sub></strong>)</p>\n</td>\n<td>\n<p><strong>Beriberi</strong></p>\n<p>Wernicke&ndash;Korsakoff&rsquo;s syndrome</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Riboflavin (<strong>B<span>2</span></strong>)</p>\n</td>\n<td>\n<p>Cheilosis, Magenta-coloured tongue,&nbsp;</p>\n<p>Glossitis, Seborrheic dermatitis</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Niacin (<strong>B<span>3</span></strong>)</p>\n</td>\n<td>\n<p><strong>Pellagra</strong></p>\n<p>Dermatitis, Diarrhea, Dementia</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Pantothenic acid (<strong>B<span>5</span></strong>)</p>\n</td>\n<td>\n<p><strong>Burning foot syndrome</strong> (historically called as \"Nutritional melalgia\")</p>\n<div class=\"page\" title=\"Page 90\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Dermatitis, enteritis, alopecia, ataxia</p>\n</div>\n</div>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td>\n<p>Pyridoxine (<strong>B<span>6</span></strong>)</p>\n</td>\n<td>\n<p>Microcytic anemia, convulsions, depression</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Biotin (<strong>B<span>7</span></strong>)</p>\n</td>\n<td>\n<p>Relatively unknown</p>\n<p>Dermatitis, atrophic glossitis, alopecia, paraesthesia, muscle pain, anorexia, hallucinations</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Folic acid (<strong>B<span>9</span></strong>)</p>\n</td>\n<td>\n<p>Megaloblastic anemia, neuropathy, neural tube defects, atrophic glossitis</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Cobalamin (<strong>B<span>12</span></strong>)</p>\n</td>\n<td>\n<p>Pernicious anemia, dementia, spinal cord degeneration, homocysteinemia</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Ascorbic acid (<strong>C</strong>)</p>\n</td>\n<td>\n<p><strong>Scurvy</strong></p>\n<p>Ecchymosis, bleeding gums, poor wound healing, fatigue, joint effusion, Scorbutic rosary</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div><hr><h3>Related Pearl: Fat-soluble vitamins</h3><table>\n<tbody>\n<tr>\n<td rowspan=\"2\"><strong>Vitamin</strong></td>\n<td rowspan=\"2\"><strong>Active form</strong></td>\n<td rowspan=\"2\"><strong>Deficiency</strong></td>\n<td rowspan=\"2\"><strong>Toxicity</strong></td>\n<td colspan=\"3\"><strong>Required dietary allowance</strong></td>\n</tr>\n<tr>\n<td>Children</td>\n<td>Male</td>\n<td>Female</td>\n</tr>\n<tr>\n<td>Vitamin A</td>\n<td>\n<p>Retinol</p>\n<p>Retinal</p>\n<p>Retinoic acid</p>\n</td>\n<td>\n<p>Night blindness, xerophthalmia,</p>\n<p>Acne, psoriasis,</p>\n<p>Impaired immunity</p>\n</td>\n<td>\n<p>Affects lysosomes</p>\n<p>Acute- pseudotumor cerebrii, exfoliative dermatitis</p>\n<p>Chronic-fractures</p>\n</td>\n<td>\n<p>390-630mcg (1-9 years)</p>\n<p>770-1000mcg (10-18 years)</p>\n</td>\n<td>1000mcg&nbsp;</td>\n<td>&nbsp;\n<p>Adult - 840mcg</p>\n<p>Pregnancy - 900mcg</p>\n<p>Lactation - 950 mcg</p>\n</td>\n</tr>\n<tr>\n<td>Vitamin D</td>\n<td>1,25-Dihydro-cholecalciferol</td>\n<td>\n<p>Children- Rickets</p>\n<p>Adults-osteomalacia</p>\n</td>\n<td>Calcinosis</td>\n<td>&nbsp;\n<p>400 IU (&lt;1 year)</p>\n<p>600 IU (&gt;1 year)</p>\n</td>\n<td>&nbsp;600 IU</td>\n<td>\n<p>Adult - 600 IU</p>\n<p>Pregnancy - 600 IU</p>\n<p>Lactation - 600 IU</p>\n</td>\n</tr>\n<tr>\n<td>Vitamin E</td>\n<td>&alpha;-tocopherol</td>\n<td>\n<p>Hemolytic anemia,</p>\n<p>axonal degeneration,</p>\n<p>spinocerebellar ataxia</p>\n</td>\n<td>\n<p>Reduced platelet aggregation,&nbsp;</p>\n<p>Interferes with vitamin K</p>\n</td>\n<td>&nbsp;5-8 mg</td>\n<td>&nbsp;10 mg</td>\n<td>\n<p>Adult - 8 mg</p>\n<p>Pregnancy - 10 mg</p>\n<p>Lactation - 12 mg</p>\n</td>\n</tr>\n<tr>\n<td>Vitamin K</td>\n<td>\n<p>Menedione</p>\n<p>Menoquinone</p>\n<p>Phyloquinone</p>\n</td>\n<td>\n<p>Elevated prothrombin time and bleeding</p>\n<p>Haemorrhagic disease of newborn</p>\n</td>\n<td>\n<p>Hemolysis</p>\n<p>Hyperbilirubinemia</p>\n<p>Kernicterus</p>\n</td>\n<td>\n<p>&lt;1 year - 2-3&nbsp;&micro;g</p>\n<p>Children - 30-50&nbsp;&micro;g</p>\n&nbsp;</td>\n<td>55 &micro;g&nbsp;</td>\n<td>55 &micro;g&nbsp;</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>Note:The <strong>RDA</strong> for <strong>Vitamin D</strong> in the <strong>elderly</strong> (&gt;60 years) is <strong>800 IU</strong>.</p><hr><h3>Related Pearl: Difference between various causes of ataxia</h3><table>\n<tbody>\n<tr>\n<td>&nbsp;</td>\n<td>\n<p><strong>Friedreich's&nbsp;</strong><strong>ataxia</strong></p>\n</td>\n<td>\n<p><strong>&nbsp;Tabes&nbsp;</strong><strong>dorsalis</strong></p>\n</td>\n<td><strong>&nbsp;SACD</strong></td>\n</tr>\n<tr>\n<td>Tract&nbsp;</td>\n<td>\n<p>Posterior column</p>\n<p>Pyramidal&nbsp;</p>\n<p>Spinocerebellar tracts&nbsp;</p>\n</td>\n<td>\n<p>Posterior column</p>\n</td>\n<td>\n<p>Posterior column</p>\n<p>Pyramidal&nbsp;</p>\n<p>Peripheral nerves</p>\n</td>\n</tr>\n<tr>\n<td>Vibration sense</td>\n<td>\n<p>Absent</p>\n</td>\n<td>Absent</td>\n<td>Absent&nbsp;</td>\n</tr>\n<tr>\n<td>Proprioception</td>\n<td>\n<p>Absent</p>\n</td>\n<td>Absent</td>\n<td>Absent</td>\n</tr>\n<tr>\n<td>Pain/Temperature</td>\n<td>\n<p>Present</p>\n</td>\n<td>Present</td>\n<td>Present</td>\n</tr>\n<tr>\n<td>Deep tendon reflex</td>\n<td>\n<p>Absent</p>\n</td>\n<td>Absent</td>\n<td>Present. Maybe lost later.</td>\n</tr>\n<tr>\n<td>Babinski sign</td>\n<td>\n<p>Present</p>\n</td>\n<td>Not Present</td>\n<td>Present</td>\n</tr>\n<tr>\n<td>Features</td>\n<td>\n<p>Cardiomyopathy</p>\n<p>Optic atrophy</p>\n<p>Diabetes mellitus</p>\n</td>\n<td>\n<p>Argyll Robertson pupil</p>\n<p>Bladder disturbance</p>\n</td>\n<td>\n<p>Vitamin B12 deficiency</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>SACD-subacute combined degeneration</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF3707",
      "difficulty": "easy"
    },
    {
      "text": "A 35-year-old male patient presented with a history of tremors, palpitation, and difficulty in closing his eyes for the past 1 month. On examination, you note the following finding as shown in the image given below. What is this sign called?",
      "choices": [
        {
          "id": 1,
          "text": "Dalrymple’s sign"
        },
        {
          "id": 2,
          "text": "Enroth's sign"
        },
        {
          "id": 3,
          "text": "Gifford's sign"
        },
        {
          "id": 4,
          "text": "Mobius sign"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>The given image shows lid retraction in the right eye, which is known as&nbsp;<strong>Dalrymple's sign.</strong></p>\n<p>It is the&nbsp;<strong>commonest</strong>&nbsp;and&nbsp;<strong>earliest sign</strong>&nbsp;of&nbsp;<strong>Grave's ophthalmopathy</strong>. It is due to overactivity of levator aponeurosis and M&uuml;ller's muscle. Here the upper lid margin is at level with or above the superior limbus, causing the upper sclera to become visible (scleral show).</p>\n<p><strong>Grave's disease</strong>&nbsp;is an<strong>&nbsp;autoimmune</strong>&nbsp;disorder that results in&nbsp;<strong>hyperthyroidism.</strong>&nbsp;In this condition, autoantibodies bind to thyroid-stimulating hormone (TSH) receptors and stimulate the secretion of thyroid hormone.&nbsp;</p>\n<p>Thyroid ophthalmopathy or thyroid eye disease can be seen in Graves' disease or even in euthyroid/ hypothyroid patients.&nbsp;<strong>Women&nbsp;</strong>and&nbsp;<strong>smokers</strong>&nbsp;are at higher risk of developing Grave's ophthalmopathy (otherwise known as<strong>&nbsp;</strong>thyroid eye disease).&nbsp;</p>\n<p><strong>Thyroid function tests&nbsp;</strong>and a&nbsp;<strong>thyroid autoantibody assay&nbsp;</strong>should be done to assess thyroid hormone status.&nbsp;</p>\n<p>Control of hyperthyroidism is effective in management. Injecting botulinum toxin to levator aponeurosis and M&uuml;ller's muscle may be done as a temporary measure.&nbsp;</p>\n<p>The other options are all signs associated with Grave's disease but do not correlate with the given image.</p><hr><h3>Related Pearl: Signs in Grave’s ophthalmopathy</h3><div>\n<table>\n<tbody>\n<tr>\n<td><strong>Sign</strong></td>\n<td><strong>Feature</strong></td>\n</tr>\n<tr>\n<td>Dalrymple's sign</td>\n<td>Retraction of the upper lids</td>\n</tr>\n<tr>\n<td>von Graefe's sign</td>\n<td>Lid lag, i.e., when the globe is moved downward, the upper lid lags behind</td>\n</tr>\n<tr>\n<td>Griffith Sign</td>\n<td>Lower lid lag on upward gaze</td>\n</tr>\n<tr>\n<td>Enroth's sign</td>\n<td>Fullness of the eyelids</td>\n</tr>\n<tr>\n<td>Stellwag's sign</td>\n<td>Infrequent blinking</td>\n</tr>\n<tr>\n<td>Gifford's sign</td>\n<td>Difficulty in eversion of the upper lid</td>\n</tr>\n<tr>\n<td>Mobius&rsquo; sign</td>\n<td>Convergence weakness</td>\n</tr>\n<tr>\n<td>Joffroy&rsquo;s sign</td>\n<td>Lack of wrinkling of the forehead on superior gaze</td>\n</tr>\n<tr>\n<td>Jellinek's Sign</td>\n<td>Abnormal pigmentation of the upper lid</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>The image given below shows Dalrymple's sign in the right eye.</p>\n</div><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/0a484751a2e640e7906b3d75f752f5b5x450x224.PNG\" alt=\"Pearl Image\"><hr><h3>Related Pearl: Werner  classification</h3><ul>\n<li>Werner classification reflects the severity of the ophthalmopathy.</li>\n<li>It is well known by the acronym of <strong>NO SPECS.</strong></li>\n<li>Each grade is further subdivided as 0-4 and a-c.</li>\n</ul>\n<p><strong>Grades of Werner classification:</strong></p>\n<table>\n<tbody>\n<tr>\n<td><strong>Grade</strong></td>\n<td><strong>Feature</strong></td>\n<td><strong>Acronym</strong></td>\n</tr>\n<tr>\n<td>0</td>\n<td>No signs or symptoms</td>\n<td><strong>N</strong></td>\n</tr>\n<tr>\n<td>1</td>\n<td>Only signs (lid retraction)</td>\n<td><strong>O</strong></td>\n</tr>\n<tr>\n<td>2</td>\n<td>Soft tissue involvement (chemosis, grit)</td>\n<td><strong>S</strong></td>\n</tr>\n<tr>\n<td>3</td>\n<td>Proptosis (minimum &lt;23mm, moderate, marked &gt;28mm)</td>\n<td><strong>P</strong></td>\n</tr>\n<tr>\n<td>4</td>\n<td>Extraocular muscle involvement</td>\n<td><strong>E</strong></td>\n</tr>\n<tr>\n<td>5</td>\n<td>Corneal involvement</td>\n<td><strong>C</strong></td>\n</tr>\n<tr>\n<td>6</td>\n<td>Loss of sight</td>\n<td><strong>S</strong></td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/c1108ee6d3e643d59050309dd57625e5.PNG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF6617",
      "difficulty": "easy"
    },
    {
      "text": "Which of the following indicators is used to measure intracellular fluid volume?",
      "choices": [
        {
          "id": 1,
          "text": "Tritium oxide and Evans blue"
        },
        {
          "id": 2,
          "text": "Deuterium oxide and inulin"
        },
        {
          "id": 3,
          "text": "Inulin and 125I-albumin"
        },
        {
          "id": 4,
          "text": "Thiosulfate and Evans blue"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p><strong>Deuterium oxide </strong>and <strong>inulin</strong> are the indicators used for the measurement of <strong>intracellular fluid volume</strong> (ICF).</p>\n<p>The ICF <strong>cannot</strong> be measured <strong>directly</strong>. It is calculated by subtracting the extracellular fluid volume (<strong>ECF</strong>) from the total body water (<strong>TBW</strong>).</p>\n<p><strong>ICF&nbsp; = TBW - ECF</strong></p>\n<p>Indicators used for the measurement of TBW are:</p>\n<ul>\n<li>Tritium oxide (<sup>3</sup>H<sub>2</sub>O)</li>\n<li><strong>Deuterium oxide (<sup>2</sup>H<sub>2</sub>O)</strong></li>\n<li>Antipyrine</li>\n</ul>\n<p>Indicators used for the measurement of <strong>ECF&nbsp;</strong>are:</p>\n<ul>\n<li><sup>22</sup>Na</li>\n<li><sup>125</sup>I-iothalamate</li>\n<li>Thiosulfate</li>\n<li><strong>Inulin</strong></li>\n</ul>\n<p>Other options:</p>\n<p>Option A: <strong>Tritium oxide </strong>and<strong> Evans blue </strong>are used for the measurement of<strong> TBW</strong> and<strong> plasma volume&nbsp;</strong>respectively.</p>\n<p>Option C:<strong> Inulin</strong> and <sup><strong>125</strong></sup><strong>I-albumin</strong> are used for the measurement of <strong>ECF volume</strong> and <strong>plasma volume&nbsp;</strong>respectively, and together, they are used to calculate the<strong> interstitial fluid volume</strong> (ECF-plasma volume).</p>\n<p>Option D:&nbsp;<strong>Thiosulfate</strong> and <strong>Evans</strong> <strong>blue</strong> are used for the measurement of <strong>ECF volume</strong> and <strong>plasma volume&nbsp;</strong>respectively, and together, they are used to calculate the <strong>interstitial</strong> <strong>fluid</strong> <strong>volume</strong> (ECF-plasma volume).</p><hr><h3>Related Pearl: Indicators for measurement of body fluids</h3><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Compartments</strong></p>\n</td>\n<td>\n<p><strong>Indicators</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Plasma volume</p>\n</td>\n<td>\n<ul>\n<li>Evans&rsquo; blue(T1824)</li>\n<li>Human serum albumin tagged with radioactive iodine<sup>125</sup></li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>\n<p>RBC volume</p>\n</td>\n<td>\n<p>Tagging RBC with cr-51, Fe-59, 32P, also antigenic tagging</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>ECF volume</p>\n</td>\n<td>\n<ul>\n<li>Inulin</li>\n<li>Sucrose</li>\n<li>Mannitol</li>\n<li>Sodium thiosulphate</li>\n<li>Sodium thiocyanate</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>\n<p>Interstitial fluid</p>\n</td>\n<td>\n<p>Cannot be measured directly.</p>\n<p>ECF minus plasma volume gives the value</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>ICF</p>\n</td>\n<td>\n<p>Cannot be measured directly.</p>\n<p>TBW minus ECF gives the value (D2O minus Mannitol)</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>TBW</p>\n</td>\n<td>\n<p>D2O (<sup>2</sup>H<sub>2</sub>O)</p>\n<p>Tritium oxide (<sup>3</sup>H<sub>2</sub>O)</p>\n<p>Antipyrine</p>\n<p>Aminopyrine</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MD0065",
      "difficulty": "medium"
    },
    {
      "text": "A 45-year-old male patient with COVID-19 infection develops shortness of breath and is brought to the hospital. His SpO2 increases from 81% to 83% on administering oxygen via facemask at 10 L/min. The decision to deliver oxygen using the device shown below is made. What is its oxygen delivery rate?",
      "choices": [
        {
          "id": 1,
          "text": "1-6 L/min"
        },
        {
          "id": 2,
          "text": "2-15 L/min"
        },
        {
          "id": 3,
          "text": "10-15 L/min"
        },
        {
          "id": 4,
          "text": "40-60 L/min"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>The equipment shown in the image is <strong>high-flow nasal cannula</strong>. It delivers oxygen at 40-60 L/min. This patient has <strong>persistent hypoxia</strong> after an adequate trial of standard oxygen therapy and should be started on <strong>high-flow nasal cannula oxygen therapy. </strong></p>\n<p><strong>High flow nasal cannula</strong> is a mode of respiratory support used in the management of acute respiratory failure. It delivers <strong>humidified gas</strong> via the nasal cannula at high flow rates.</p>\n<ul>\n<li>HFNC can deliver oxygen at 40 L/min, 37°C, and 99.9% relative humidity.</li>\n<li>The <strong>high-flow oxygen</strong> is delivered directly to the nasopharynx. This produces <strong>FiO<sub>2</sub></strong> equal to that delivered by traditional mask devices.</li>\n<li>The benefits of HFNC include <strong>reduced work</strong> of breathing, <strong>improved gas exchange</strong> by nasopharyngeal dead-space washout, and <strong>decreased</strong> <strong>energy</strong> required to <strong>humidify</strong> and <strong>heat</strong> respiratory gases.</li>\n</ul>\n<p>The HFNC equipment shown in the image below uses a heated humidifier (named PMH200), a nasal cannula (No. 2), and a ventilator (brand: vivo30).</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/3aebb44bf51947339bd67c0ef0bc717ex512x525.PNG\" alt=\"Explanation Image\"><p><strong><br />Other options:</strong></p>\n<table>\n<tbody>\n<tr>\n<td><strong>Oxygen delivery devices</strong></td>\n<td><strong>Flow rate (liter/min) </strong></td>\n<td><strong>Approximate FiO<sub>2</sub></strong></td>\n</tr>\n<tr>\n<td>Nasal cannula </td>\n<td>1-6 </td>\n<td>0.24-0.44 </td>\n</tr>\n<tr>\n<td>Simple face mask </td>\n<td>6-10</td>\n<td>0.40-0.60</td>\n</tr>\n<tr>\n<td>Non-rebreathing mask</td>\n<td>10-15</td>\n<td>0.90-1.00 </td>\n</tr>\n<tr>\n<td>Venturi mask </td>\n<td>2-15 </td>\n<td>0.24-0.60</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p> </p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/830ff59bb60643dd907d3b8157545fe2x1280x1280.PNG\" alt=\"Explanation Image\"><p><br />The image below shows a non-rebreathing mask.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/2d9a526f186649dabbf96fed3f12c658x720x960.JPEG\" alt=\"Explanation Image\"><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/e9e6523971b7493b9ef0d7937aec36c9x1279x1173.JPEG\" alt=\"Explanation Image\">",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/2c59e9d848f14caab96b7e72d5defc07.JPEG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF1036",
      "difficulty": "medium"
    },
    {
      "text": "Which national health program's logo is shown below?",
      "choices": [
        {
          "id": 1,
          "text": "Directly observed therapy short course"
        },
        {
          "id": 2,
          "text": "National tuberculosis elimination program"
        },
        {
          "id": 3,
          "text": "End TB strategy"
        },
        {
          "id": 4,
          "text": "National tobacco control program"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>The given logo is of the <strong>National Tuberculosis Elimination Program</strong> (NTEP).</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/0aedca5099294ed49330a2c7c486d988x1280x1259.JPEG\" alt=\"Explanation Image\"><p>The Revised National Tuberculosis Control Programme<strong> (RNTCP)</strong> was started in the year 1997 and aims at diagnosing and caring for TB cases both in the public and private sectors. It undertook a <strong>DOTS</strong> (Directly Observed Therapy Short course) strategy that <strong>ensures </strong>a <strong>cure</strong> by <strong>providing</strong> and <strong>confirming</strong> that the most <strong>effective medicine</strong> is taken. The logo of DOTS is shown below.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/b0bc3d437ffc43458595dcc9923c1fb0x240x210.PNG\" alt=\"Explanation Image\"><p>RNTCP was <strong>renamed</strong> National Tuberculosis Elimination Program (NTEP) on <strong>1st January 2020</strong> with the aim to eliminate TB by 2025, 5 years ahead of the WHO End TB strategy which is the global target. In May 2014, the WHO launched the <strong>End TB strategy,</strong> which formed a <strong>framework</strong> to <strong>guide</strong> countries toward ending the <strong>TB</strong> <strong>epidemic</strong> by <strong>decreasing</strong> TB <strong>mortality, and incidence</strong> and <strong>eliminating</strong> the <strong>financial burden</strong> of the disease. The logo of the End TB strategy is shown below. </p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/4a8c18ed58f84dc98fe0aea874a94e8cx225x225.PNG\" alt=\"Explanation Image\"><p>The <strong>National Tobacco Control Programme</strong> (NTCP) was launched by the government in 2007-08 during the <strong>11th five-year plan</strong>, with the aim to generate <strong>awareness</strong> about the <strong>harmful effects</strong> of tobacco consumption and smoking. It also aimed to <strong>reduce</strong> the <strong>production</strong> and supply of tobacco products and facilitate the <strong>implementation</strong> of <strong>strategies</strong> for the <strong>prevention</strong> and <strong>control</strong> of <strong>tobacco</strong> advocated by the <strong>WHO</strong> framework convention on tobacco control. </p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/c9a7b46eb5aa46589568e787f5cb8d52x146x119.PNG\" alt=\"Explanation Image\"><hr><h3>Related Pearl: Diagnostic algorithm for Pulmonary TB – National Tuberculosis Elimination Programme (NTEP) 2020 Guidelines</h3><p>Any case of&nbsp;<strong>presumptive pulmonary TB</strong>&nbsp;should undergo <strong>sputum examination + chest X-ray + CB-NAAT</strong></p>\n<ul>\n<li>If sputum and chest X-ray normal:<strong> rule out TB and refer</strong></li>\n<li>If sputum is positive and CB NAAT is positive:<strong>&nbsp;microbiologically confirmed case of TB</strong></li>\n</ul>\n<p>The following protocol is used for <strong>CB-NAAT testing:</strong></p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/e8d17e5087654b588b4b519b350acb71x1280x2558.JPEG\" alt=\"Pearl Image\">",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/f4140cfd744244f98c6ba011a02529ea.JPEG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "ME6014",
      "difficulty": "medium"
    },
    {
      "text": "A patient was started on a drug for the treatment of glaucoma. He presents with complaints of extensive loss of orbital fat giving the appearance of a sunken eye. Which of the following drugs is most likely to cause this side effect?",
      "choices": [
        {
          "id": 1,
          "text": "Timolol"
        },
        {
          "id": 2,
          "text": "Pilocarpine"
        },
        {
          "id": 3,
          "text": "Acetazolamide"
        },
        {
          "id": 4,
          "text": "Latanoprost"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>The given clinical scenario is suggestive of orbital fat atrophy and it is seen with&nbsp;<strong>topical PGF2&alpha; (prostaglandin) analogs&nbsp;</strong>like<strong>&nbsp;latanoprost.</strong></p>\n<p>Topical PGF2 alpha (prostaglandin) analogs are used as a first line in glaucoma.&nbsp;<strong>Latanoprost</strong>&nbsp;is the<strong>&nbsp;most&nbsp;commonly</strong>&nbsp;used anti-glaucoma medication. Other prostaglandin analogues are travoprost, bimatoprost, tafluprost, and unoprostone.</p>\n<p>Mechanism of action: It&nbsp;<strong>reduces intraocular pressure</strong>&nbsp;by altering the ciliary muscle tension and improving the&nbsp;<strong>outflow</strong>&nbsp;of the aqueous humor.</p>\n<p>Adverse effects:</p>\n<ul>\n<li>Blurring of vision</li>\n<li>Iris pigmentation</li>\n<li>Thickening and darkening of eyelashes</li>\n<li>Macular edema&nbsp;especially in aphakic patients.&nbsp;</li>\n<li><strong>Orbital fat atrophy</strong></li>\n</ul>\n<p>Other options:</p>\n<p>Option A:<strong> Timolol</strong>&nbsp;is a&nbsp;<strong>non-selective beta-blocker</strong>&nbsp;used topically in glaucoma. Ocular adverse effects of beta-blockers include&nbsp;<strong>dryness</strong>&nbsp;and&nbsp;<strong>redness</strong>&nbsp;of the eye, stinging, corneal hypoesthesia, blurred vision, and allergic blepharoconjunctivitis. Systemic side effects like bradycardia and bronchospasm may be seen due to absorption through the nasolacrimal duct.</p>\n<p>Option B: <strong>Pilocarpine</strong>&nbsp;is a&nbsp;<strong>miotic</strong>&nbsp;agent and adverse effects are corneal edema, miosis, induced myopia, and retinal detachment.</p>\n<p>Option C:<strong> Acetazolamide</strong>&nbsp;is a&nbsp;<strong>carbonic anhydrase inhibitor&nbsp;</strong>and reduces intraocular pressure by&nbsp;<strong>reducing&nbsp;</strong>the<strong>&nbsp;aqueous humor formation.&nbsp;</strong>It&nbsp;is given orally and the systemic adverse effects are anorexia, paresthesia, hypokalemia, acidosis, and depression.</p><hr><h3>Related Pearl: Important adverse effects of anti-glaucoma drugs</h3><table>\n<tbody>\n<tr>\n<td><span><strong>Anti-glaucoma drug</strong></span></td>\n<td><span><strong>The adverse effects</strong></span></td>\n</tr>\n<tr>\n<td><span>Beta-blockers</span></td>\n<td>\n<p><span>Corneal hypoesthesia</span></p>\n<p><span>Systemic side effects</span></p>\n</td>\n</tr>\n<tr>\n<td><span>Sympathomimetics</span></td>\n<td>\n<p><span>Lid retraction</span></p>\n<p><span>CNS depression and apnea in infants and children (&lt;2 years)</span></p>\n</td>\n</tr>\n<tr>\n<td><span>Prostaglandin analogs</span></td>\n<td>\n<p><span>Eyelash hypertrichosis</span></p>\n<p><span>Macular edema</span></p>\n<p><span>Iris pigmentation (Heterochromia iridis)</span></p>\n<p><span>Peri-orbital fat depletion</span></p>\n</td>\n</tr>\n<tr>\n<td><span>Miotics</span></td>\n<td>\n<p><span>Retinal detachment</span></p>\n<p><span>Cataract</span></p>\n</td>\n</tr>\n<tr>\n<td><span>Carbonic anhydrase inhibitors</span></td>\n<td>\n<p><span>Systemic side effects</span></p>\n<p><span>Corneal edema</span></p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div><hr><h3>Related Pearl: Antiglaucoma drugs: Mechanism of lowering intraocular pressure (IOP) at a glance</h3><p><strong>Drugs that increase trabecular outflow</strong></p>\n<ul>\n<li>Miotics (e.g., pilocarpine)</li>\n<li>Epinephrine, dipivefrine</li>\n<li>Bimatoprost</li>\n<li>Rho-kinase inhibitor (Netarsudil)</li>\n</ul>\n<p><strong>Drugs that increase uveoscleral outflow</strong></p>\n<ul>\n<li>Prostaglandins (latanoprost)</li>\n<li>Epinephrine, dipivefrine</li>\n<li>Brimonidine</li>\n<li>Apraclonidine</li>\n</ul>\n<p><strong>Drugs that decrease aqueous production</strong></p>\n<ul>\n<li>Carbonic anhydrase inhibitors (e.g., acetazolamide, dorzolamide)</li>\n<li>Alpha receptor stimulators in ciliary process (e.g., epinephrine, dipivefrine, clonidine, brimonidine, apraclonidine)</li>\n<li>Beta-blockers</li>\n</ul>\n<p><strong>Hyperosmotic agents</strong> - (e.g., glycerol, mannitol, urea)</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/52d74961d2524b3bb5c22c2677259778x1280x1532.JPEG\" alt=\"Pearl Image\">",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF6619",
      "difficulty": "medium"
    },
    {
      "text": "A patient was diagnosed with multibacillary leprosy. For how long should she be treated and monitored for relapse, respectively?",
      "choices": [
        {
          "id": 1,
          "text": "6 months, 2 years"
        },
        {
          "id": 2,
          "text": "6 months, 3 years"
        },
        {
          "id": 3,
          "text": "12 months, 5 years"
        },
        {
          "id": 4,
          "text": "12 months, 10 years"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>A patient with&nbsp;<strong>multibacillary leprosy</strong>&nbsp;should be <strong>treated</strong> for&nbsp;<strong>12 months&nbsp;</strong>and <strong>monitored for relapse</strong> for at least <strong>5 years.</strong></p>\n<p>Leprosy is a chronic infectious disease that mainly affects the skin, the peripheral nerves, upper respiratory tract mucosa, and the eyes caused by&nbsp;<em>Mycobacterium leprae. </em>If&nbsp;left untreated, it can lead to permanent damage to the skin, nerves, limbs, and eyes.</p>\n<p>Leprosy is classified as paucibacillary (PB) or multibacillary (MB).&nbsp;<strong>Paucibacillary</strong>&nbsp;leprosy refers to cases with <strong>1-5 skin lesions</strong>, <strong>no or only 1 involved</strong> <strong>nerve</strong>, with <strong>no bacilli</strong> in a skin smear.&nbsp;<strong>Multibacillary</strong>&nbsp;leprosy refers to cases with <strong>&gt;5 skin lesions,</strong>&nbsp;with <strong>&gt;1&nbsp;nerve involvement</strong>, or with the <strong>presence of bacilli</strong> in the skin smear, irrespective of the number of skin lesions.</p>\n<p>WHO recommends multidrug therapy (MDT) for the treatment of leprosy. The currently recommended MDT regimen includes <strong>dapsone, rifampicin</strong> and <strong>clofazimine</strong>. It is given for&nbsp;<strong>6 months</strong> in <strong>paucibacillary</strong> leprosy and <strong>12 months</strong> for <strong>multibacillary</strong> cases.&nbsp;</p>\n<div class=\"page\" title=\"Page 1430\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>The majority of the cases are cured following MDT, however, relapse may occur. A <strong>multibacillary patient</strong> has to be <strong>monitored for 5 years</strong> and the <strong>paucibacillary patient</strong> has to be <strong>monitored for 2 years</strong> after completion of treatment.</p>\n<p>The blister pack provided for the treatment of multibacillary leprosy is shown below.</p>\n</div>\n</div>\n</div><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/df1b88f8af0a487786d1a18785861967x307x146.JPEG\" alt=\"Explanation Image\">",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB0834",
      "difficulty": "easy"
    },
    {
      "text": "A middle-aged male patient who is under mechanical positive pressure ventilation developed a sudden drop in saturation. BP is 90/60 mmHg, respiratory rate is 40 breaths per minute, and pulse rate is 120 bpm. The chest x-ray is given below. What is the diagnosis and the immediate step of management for this patient?",
      "choices": [
        {
          "id": 1,
          "text": "Left cardiac tamponade; Pericardiocentesis"
        },
        {
          "id": 2,
          "text": "Right cardiac tamponade; Pericardiocentesis"
        },
        {
          "id": 3,
          "text": "Left -sided tension pneumothorax; Needle thoracostomy"
        },
        {
          "id": 4,
          "text": "Right-sided tension pneumothorax; Chest tube insertion"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>The given clinical scenario along with the x-ray points to a diagnosis of <strong>left-sided tension pneumothorax</strong>. Immediate<strong> needle thoracostomy</strong> with a wide-bore needle in the fifth intercostal space should be done in order to prevent cardiovascular collapse.</p>\n<p>The given <strong>x-ray</strong> features showing a well-demarcated area <strong>devoid</strong> of <strong>lung markings</strong> on the <strong>left</strong> side with <strong>tracheal deviation</strong> and the<strong> mediastinal shift</strong> to the<strong> right side,</strong> along with the clinical scenario is suggestive of <strong>tension pneumothorax.</strong></p>\n<p>Tension pneumothorax is a<strong> clinical diagnosis, </strong>and treatment should never be delayed while waiting for radiological confirmation. Imaging modalities used are ultrasound–extended focused assessment with sonar for trauma (<strong>eFAST</strong>), chest x-ray, and spiral CT.</p>\n<p>A tension pneumothorax develops when there is a<strong> </strong>tear either in the <strong>parietal</strong> or <strong>visceral pleura</strong>. This tear acts as a <strong>one-way valve </strong>i.e. air enters from the lung or chest wall through it during inspiration but has no way to escape during expiration. This ultimately leads to the <strong>collapse</strong> of the<strong> affected lung</strong>.</p>\n<p>It usually occurs following <strong>penetrating</strong> or blunt <strong>chest trauma,</strong> iatrogenic lung injury, or <strong>mechanical positive pressure ventilation</strong>.</p>\n<p>It is characterized by:</p>\n<ul>\n<li>Chest pain</li>\n<li><strong>Tachypnoea</strong>, and acute dyspnea</li>\n<li>Sudden onset <strong>hemodynamic compromise</strong> (<strong>tachycardia, hypotension, low O<sub>2</sub> saturation</strong>, loss of consciousness)</li>\n<li>Neck vein distension</li>\n<li><strong>Tracheal deviation</strong> away from the side of the injury </li>\n<li>Decreased chest movements on the affected side</li>\n<li><strong>Hyper-resonance</strong> on percussion on the affected side</li>\n<li><strong>Absence</strong> or <strong>decreased</strong> <strong>breath sounds </strong>on the affected side</li>\n</ul>\n<p>Management of tension pneumothorax:</p>\n<ul>\n<li><strong>Immediate </strong>management- <strong>needle decompression</strong> or <strong>needle thoracostomy</strong> i.e. insertion of a wide-bore needle in the 5th ICS anterior to the mid-axillary line.</li>\n<li><strong>Definitive</strong> management- <strong>tube thoracostomy</strong> or <strong>chest tube insertion</strong> in the 5th ICS in the<strong> triangle of safety, </strong>identified as a triangle that lies anterior to the mid-axillary line above the nipple, below, and lateral to the pectoralis major muscle.</li>\n</ul>\n<p>The x-ray below shows a <strong>left-sided tension pneumothorax</strong>. The yellow arrows are pointing to the tracheal deviation and the mediastinal shift to the right side.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/33d12882a129422b9950446756d39eccx1279x1186.PNG\" alt=\"Explanation Image\"><p>Other options:</p>\n<p><strong>Cardiac tamponade</strong> is characterized by the presence of <strong>hypotension</strong>, distended jugular veins, and muffled heart sounds (<strong>Beck's triad</strong>). The <strong>breath sounds</strong> are <strong>absent</strong> in <strong>tension pneumothorax</strong> while they are present in cardiac tamponade.<strong> Pericardiocentesis </strong>is done in cases of cardiac tamponade.  </p>",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/0ea5ea36ec07498fa5a9b03ca5d59e7d.JPEG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA0001",
      "difficulty": "easy"
    },
    {
      "text": "A female patient presents with nasal obstruction, nasal discharge, and loss of smell. On examination of the nose, she has roomy nasal cavities, foul-smelling discharge, and dry greenish crusts. She is also found to have merciful anosmia. What is the diagnosis?",
      "choices": [
        {
          "id": 1,
          "text": "Atrophic rhinitis"
        },
        {
          "id": 2,
          "text": "Nasal polyps"
        },
        {
          "id": 3,
          "text": "Allergic rhinitis"
        },
        {
          "id": 4,
          "text": "Foreign body"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>The clinical vignette of<strong> merciful anosmia</strong>, <strong>foul-smelling discharge,</strong> and<strong> roomy nasal cavities</strong>, with<strong> dry greenish crusts</strong>, points to a diagnosis of <strong>atrophic rhinitis</strong>.</p>\n<p>Atrophic rhinitis is a <strong>chronic inflammation</strong> of the nose characterized by <strong>atrophy</strong> of <strong>nasal mucosa</strong> and <strong>turbinate bones. </strong>The exact etiology of this condition is not known. It is more common in <strong>females</strong> and starts around <strong>puberty</strong>.&nbsp;</p>\n<p>Clinically patients present with <strong>nasal obstruction, foul odor,</strong> and<strong> merciful anosmia. </strong>Merciful anosmia is when the patient has <strong>marked anosmia</strong> and is unable to smell the <strong>foul odor</strong>&nbsp;coming from their nose.</p>\n<p>On examination of the nose,<strong> greenish</strong> or<strong> greyish crusting</strong> of the nasal passage, pale nasal mucosa, atrophied nasal turbinates, and epistaxis following the removal of the crusts. The <strong>roomy nasal cavity</strong> is seen due to the resorption of bones of the turbinates.</p>\n<p>Treatment:</p>\n<ul>\n<li><strong>Nasal irrigation -&nbsp;</strong>using&nbsp;<strong>warm saline</strong>&nbsp;or an&nbsp;<strong>alkaline&nbsp;solution</strong>&nbsp;composed of sodium bicarbonate 1 part, sodium biborate 1 part, sodium chloride 2 parts in 280 mL of water.</li>\n<li>Local antibiotics -&nbsp;<strong>Kemicetine antiozena</strong>&nbsp;solution&nbsp;containing&nbsp;<strong>chloromycetin, estradiol, and vitamin D2.&nbsp;</strong></li>\n<li>25% glucose in glycerine,&nbsp;estradiol spray, systemic use of streptomycin, potassium iodide,&nbsp;placental extract.</li>\n<li>Surgical&nbsp;management:\n<ul>\n<li><strong>Young's operation</strong>: In this procedure, flaps are raised within the nasal vestibule and both the nostrils are completely closed and&nbsp;are opened after 6 months. During this time, the mucosa may revert to normal and the crusting is reduced.</li>\n<li><strong>Modified Young's operation: </strong>In this procedure, the nostrils are <strong>partially closed</strong> and thereby&nbsp;avoiding the discomfort of complete closure of the nostrils. The results are the same compared to Young's operation.</li>\n<li>Narrowing of the nasal cavity can be done by submucosal injection of <strong>Teflon paste</strong>, or by insertion of fat, cartilage, or Teflon strips under the mucoperiosteum.</li>\n</ul>\n</li>\n</ul>\n<p>Other options:</p>\n<p>Option B: <strong>Nasal polyps</strong> are non-neoplastic masses of the edematous nasal or sinus mucosa. Nasal polyps can be antrochoanal polyps or ethmoidal polyps. They present with a polypoid mass in the nose.</p>\n<p>Option C: <strong>Allergic rhinitis</strong> is associated with inferior turbinate hypertrophy and can cause chronic nasal obstruction. It is characterized by watery nasal discharge, sneezing, and itching in the nose.</p>\n<p>Option D: <strong>Foreign body nose</strong> is commonly seen in children. The child presents with unilateral, foul-smelling nasal discharge.</p><hr><h3>Related Pearl: Etiology of atrophic rhinitis</h3><p>Etiology of <strong>primary atrophic rhinitis</strong>:</p>\n<ul>\n<li>Hereditary- Involves more than one member of a family</li>\n<li>Endocrinal- More common in females, starts at puberty and regresses after menopause</li>\n<li>Racial- More common in mongoloid and caucasian races</li>\n<li>Nutritional deficiency- Vitamin A, D, iron deficiencies</li>\n<li>Autoimmune- Antigens of the nasal mucosa</li>\n<li>Organism- Klebsiella ozaenae</li>\n</ul>\n<p>Etiology of <strong>secondary atrophic rhinitis</strong>:</p>\n<ul>\n<li>Specific infections like syphilis, lupus, leprosy and, rhinoscleroma</li>\n<li>Long-standing purulent sinusitis</li>\n<li>Radiotherapy to nose</li>\n<li>Excessive surgical removal of turbinates</li>\n<li>Diphtheroids, Proteus vulgaris, Escherichia coli, staphylococci and streptococci</li>\n</ul><hr><h3>Related Pearl: Clinical Features of Atrophic Rhinitis</h3><p>Atrophic rhinitis is more common in <strong>females</strong>&nbsp;and usually <strong>starts at puberty.&nbsp;</strong>It is a <strong>bilateral condition.</strong></p>\n<ul>\n<li>Symptoms: <br />\n<ul>\n<li><strong>Foul smell</strong> from the nose</li>\n<li><strong>Nasal</strong> <strong>obstruction</strong> in spite of roomy chambers due to large crusts filling nasal cavity</li>\n<li><strong>Epistaxis</strong> on removing of the crusts</li>\n<li>Anosmia due to degeneration of nerve elements (<strong>merciful anosmia</strong>).</li>\n</ul>\n</li>\n<li>Signs: <br />\n<ul>\n<li>Greenish or greyish black dry crusts covering the turbinates and septum</li>\n<li>After removal of crusts, nasal cavities appear <strong>roomy</strong> with <strong>atrophy</strong> <strong>of turbinates</strong></li>\n<li>Nasal mucosa appears <strong>pale.</strong></li>\n</ul>\n</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF6609",
      "difficulty": "easy"
    },
    {
      "text": "A mother brings her 7-year-old daughter with the complaint that the child wakes up at night screaming, sweating, and terrified. She does not respond to the comforting efforts by her parents. She does not recall the episode in the morning. In which stage of sleep do the episodes experienced by the daughter occur?",
      "choices": [
        {
          "id": 1,
          "text": "NREM stage 1"
        },
        {
          "id": 2,
          "text": "REM sleep"
        },
        {
          "id": 3,
          "text": "NREM stages 3, 4"
        },
        {
          "id": 4,
          "text": "NREM stage 2"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p><span data-preserver-spaces=\"true\">The child who wakes up with intense fear and signs of arousal such as sweating, and does not recall the event in the morning is experiencing <strong>sleep terrors</strong> or<strong> n</strong></span><strong>ight terrors.&nbsp;</strong><span data-preserver-spaces=\"true\">Night terrors occur in deep sleep&nbsp;</span><strong><span data-preserver-spaces=\"true\">(stages 3 and 4 of NREM sleep).</span></strong></p>\n<p>Sleep terror or night terror is an <strong>NREM sleep arousal disorder.</strong> In this condition, the patient experiences <strong>sudden arousal</strong> with <strong>intense fearfulness</strong>. They may have a piercing <strong>scream</strong> or <strong>cry</strong> with manifestations of <strong>intense anxiety</strong>.</p>\n<p>On arousal, they sit up in bed, are <strong>unresponsive to stimuli</strong>, and are <strong>confused</strong> and <strong>disoriented</strong> <strong>on</strong> <strong>awakening</strong>. <strong>Autonomic disturbances</strong> may be present. If vocal, they are <strong>incoherent</strong>. The patient <strong>cannot</strong> generally <strong>be awakened</strong> and efforts to calm them are not successful.&nbsp;&nbsp;</p>\n<p>Sleep terrors&nbsp;only have brief frightening or vivid images, or may not have imagery at all. It can be <strong>provoked</strong> by <strong>sleep</strong> <strong>deprivation</strong>, <strong>fever</strong>, and central nervous system <strong>depressant</strong> <strong>withdrawal</strong>.&nbsp;</p>\n<p><span data-preserver-spaces=\"true\">Nightmares have elaborate dream sequences<strong>&nbsp;without autonomic disturbances</strong>. They occur in <strong>REM sleep.</strong> The patient <strong>can be aroused</strong> and typically remembers the dream.</span></p>\n<p><span data-preserver-spaces=\"true\">The various stages of sleep and their appearance on EEG are summarized in the image below.</span></p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/85c8452da2eb4fb99f572735f5b40413x1280x2592.JPEG\" alt=\"Explanation Image\"><hr><h3>Related Pearl: Events occurring in NREM and REM sleep</h3><p>Events occurring during <strong>NREM&nbsp;stages 3 and 4</strong>:</p>\n<table>\n<tbody>\n<tr>\n<td>\n<p><span><strong>Events</strong></span></p>\n</td>\n<td>\n<p><span><strong>Description</strong></span></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><span><strong>Somnambulism</strong></span></p>\n</td>\n<td>\n<p><span>Sleepwalking</span></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><span><strong>Sleep terror or Night terror</strong></span></p>\n</td>\n<td>\n<p><span>Also called pavor nocturnus.</span></p>\n<p><span>Awakens with a scream or intense anxiety. Has increased autonomic disturbances.</span></p>\n<p><span>They do not have a memory of this when they wake up.</span></p>\n<p><span>Runs in families and seen more frequently in childhood and boys.</span></p>\n<p><span>Treatment with benzodiazepines is rarely required.</span></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><span><strong>Nocturnal enuresis</strong></span></p>\n</td>\n<td>\n<p><span>Behavioral therapy is the mainstay.</span></p>\n<p><span>Drugs like desmopressin and imipramine are used.</span></p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>&nbsp;</p>\n<p>Events occurring in <strong>REM sleep</strong>:</p>\n<table>\n<tbody>\n<tr>\n<td>\n<p><span><strong>Events</strong></span></p>\n</td>\n<td>\n<p><span><strong>Description</strong></span></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><span><strong>Nightmares</strong></span></p>\n</td>\n<td>\n<p><span>Fearful sleep without autonomic disturbances that are well remembered in the morning.</span></p>\n<p><span>TCAs may be used for treatment.</span></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><span><strong>Nocturnal penile tumescence</strong></span></p>\n</td>\n<td>\n<p><span>A normal phenomenon that can be used to differentiate between psychogenic and organic impotence.</span></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><span><strong>Narcolepsy</strong></span></p>\n</td>\n<td>\n<p><span>A disorder of the REM sleep characterized by disturbed sleep in the night, leading to excessive sleep in the morning.</span></p>\n<p><span>Associated with symptoms such as cataplexy, hypnogogic and hypnopompic hallucination, and sleep paralysis.</span></p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>&nbsp;<strong>*Hypnogogic hallucinations</strong> are those that occur at the start of sleep and <strong>hypnopompic hallucinations</strong> are those that occur at the end of sleep.</p>\n<p>&nbsp;</p>\n<p>Others:</p>\n<table>\n<tbody>\n<tr>\n<td>\n<p><span><strong>Events</strong></span></p>\n</td>\n<td>\n<p><span><strong>Description</strong></span></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><span><strong>Bruxism&nbsp;</strong>(teeth grinding)</span></p>\n</td>\n<td>\n<p><span>Occurs in stage 2 NREM sleep.</span></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><span><strong>Frontal lobe epilepsy</strong></span></p>\n</td>\n<td>\n<p><span>Occurs in stage 2 NREM sleep.</span></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><span><strong>Sleep talking</strong></span></p>\n</td>\n<td>\n<p><span>Occurs in all stages of sleep and may accompany night terrors and sleepwalking.</span></p>\n<p><span>Common in children.</span></p>\n<p><span>No treatment is necessary.</span></p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div><hr><h3>Related Pearl: Stages of Arousal and Sleep</h3><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Stage</strong></p>\n</td>\n<td>\n<p><strong>Behaviour</strong></p>\n</td>\n<td>\n<p><strong>EEG</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Alert wakefulness</p>\n</td>\n<td>\n<p>Awake, alert with eyes open</p>\n</td>\n<td>\n<p><strong>Beta rhythm</strong>(14-30 Hz)</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Relaxed wakefulness</p>\n</td>\n<td>\n<p>Awake, relaxed with eyes closed</p>\n</td>\n<td>\n<ul>\n<li><strong>Mainly alpha rhythm</strong> (8&ndash;13 Hz)</li>\n<li>Changes to the beta rhythm in response to internal or external stimuli.</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>\n<p>Relaxed drowsiness</p>\n</td>\n<td>\n<ul>\n<li>Fatigued and tired</li>\n<li>The head droops, momentary lapses of attention</li>\n<li>Sleepy but not asleep</li>\n</ul>\n</td>\n<td>\n<p><strong>Decrease in alpha-wave</strong> amplitude and frequency</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>NREM 1 (N1) (5%)</p>\n</td>\n<td>\n<ul>\n<li><strong>Light sleep-easily aroused</strong> by moderate stimuli or even by muscle jerks</li>\n<li>Continuous lack of awareness</li>\n</ul>\n</td>\n<td>\n<ul>\n<li><strong>Mixed frequency waves&nbsp;</strong> (predominantly 2-7 Hz).</li>\n<li>Gap in alpha rhythm is filled with theta (4&ndash;8 Hz) and delta (slower than 4 Hz) activity</li>\n<li><strong>Vertex waves</strong></li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>\n<p>NREM 2 (N2) (50-60%)</p>\n</td>\n<td>\n<p>Further lack of sensitivity to activation and arousal</p>\n</td>\n<td>\n<ul>\n<li><strong>Predominant theta activity</strong> (4-7 Hz)</li>\n<li><strong>K-complex and sleep spindles</strong> occur periodically</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>\n<p>NREM 3 and 4 (N3) (15-20%)</p>\n</td>\n<td>\n<ul>\n<li><strong>Deep sleep</strong></li>\n<li>Arousal only with vigorous stimuli</li>\n<li><strong>Sleep-arousal most difficult</strong></li>\n</ul>\n</td>\n<td>\n<p><strong>Delta&gt;theta activity</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>REM (paradoxical) sleep (20-25%)</p>\n</td>\n<td>\n<ul>\n<li>50&ndash;90 min after sleep onset, episodes repeated every 60&ndash;90 min, each episode lasting about 10 min</li>\n<li><strong>Dreaming occurs, rapid eye movements,</strong> increase in brain O<sub>2 </sub>consumption</li>\n</ul>\n</td>\n<td>\n<ul>\n<li>EEG resembles that of alert awake state.</li>\n<li><strong>Saw tooth waves</strong></li>\n</ul>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>Note:&nbsp;According to the new classification, stage 3 and 4 of NREM are grouped together as N3. So as per recent staging NREM has 3 stages (N1, N2, N3)</p><hr><h3>Related Pearl: Difference between  NREM and REM Sleep</h3><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Physiological Process</strong></p>\n</td>\n<td>\n<p><strong>NREM</strong></p>\n</td>\n<td>\n<p><strong>REM</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Brain activity</p>\n</td>\n<td>\n<p>Decreases from wakefulness</p>\n</td>\n<td>\n<p>Increases in motor and sensory areas, while other areas are similar to&nbsp;NREM</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Heart rate</p>\n</td>\n<td>\n<p>Slows from wakefulness</p>\n</td>\n<td>\n<p>Increases and varies compared to&nbsp;NREM</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Blood pressure</p>\n</td>\n<td>\n<p>Decreases from wakefulness</p>\n</td>\n<td>\n<p>Increases (up to 30 percent) and varies from&nbsp;NREM</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Sympathetic nerve activity</p>\n</td>\n<td>\n<p>Decreases from wakefulness</p>\n</td>\n<td>\n<p>Increases significantly from wakefulness</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Muscle tone</p>\n</td>\n<td>\n<p>Similar to wakefulness</p>\n</td>\n<td>\n<p>Absent</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Blood flow to brain</p>\n</td>\n<td>\n<p>Decreases from wakefulness</p>\n</td>\n<td>\n<p>Increases from&nbsp;NREM, depending on brain region</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Respiration</p>\n</td>\n<td>\n<p>Decreases from wakefulness</p>\n</td>\n<td>\n<p>Increases and&nbsp; varies from&nbsp;NREM, but may show brief stoppages; coughing suppressed</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Airway resistance</p>\n</td>\n<td>\n<p>Increases from wakefulness</p>\n</td>\n<td>\n<p>Increases and&nbsp; varies from wakefulness</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Body temperature</p>\n</td>\n<td>\n<p>Is regulated at lower set point than wakefulness; shivering initiated at lower temperature than during wakefulness</p>\n</td>\n<td>\n<p>Is not regulated; no shivering or sweating; temperature drifts toward that of the local environment</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Sexual arousal</p>\n</td>\n<td>\n<p>Occurs infrequently</p>\n</td>\n<td>\n<p>Greater than&nbsp;NREM</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "ME4768",
      "difficulty": "medium"
    },
    {
      "text": "A person working in the smelting industry presents with the finding as shown below. She also complains of painful paresthesia over the hands and feet. What is the most probable diagnosis?",
      "choices": [
        {
          "id": 1,
          "text": "Arsenic poisoning"
        },
        {
          "id": 2,
          "text": "Chromium poisoning"
        },
        {
          "id": 3,
          "text": "Mercury poisoning"
        },
        {
          "id": 4,
          "text": "Lead poisoning"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>The given clinical features and the image showing<strong> hyperkeratosis</strong> of palms are suggestive of chronic <strong>arsenic poisoning.</strong></p>\n<p>Acute poisoning:&nbsp;<strong>Resembles cholera</strong>; garlicky odor.</p>\n<p>Chronic poisoning:</p>\n<ul>\n<li class=\"p1\"><strong>Raindrop pigmentation is seen</strong>&nbsp;on temples, eyelids, and neck</li>\n<li class=\"p1\"><strong>Aldrich-Mee&rsquo;s lines&nbsp;</strong>(transverse white striae on the fingernails)</li>\n<li class=\"p1\">Hyperkeratosis of palms and soles</li>\n<li class=\"p1\">Painful paresthesia of hands and feet</li>\n<li class=\"p1\">The red velvety appearance of the stomach</li>\n<li class=\"p1\"><strong>Blackfoot disease -</strong>&nbsp;a gangrenous condition affecting the extremities</li>\n</ul>\n<p class=\"p1\">Tests to detect Arsenic poisoning:</p>\n<ul>\n<li class=\"p1\"><strong>Marsh test and Reinsch test</strong></li>\n</ul>\n<p class=\"p1\">Treatment:</p>\n<ul>\n<li><strong>Freshly prepared hydrated ferric oxide</strong></li>\n<li>BAL (British anti-Lewisite)</li>\n<li>Penicillamine (If BAL is not available)</li>\n</ul>\n<p class=\"p1\">&nbsp;<strong>Mee&rsquo;s lines</strong> - Transverse white striae of the fingernails are shown below.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/6d5a0e05abc8480f8f2dcd18a335fce7x1158x990.JPEG\" alt=\"Explanation Image\"><p>Hyperkeratosis of palms and soles is shown below.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/b113a4ce4fc2491ab165bf23119653d7x320x261.JPEG\" alt=\"Explanation Image\"><p>Raindrop pigmentation is shown below.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/cbb01b47d44f44c383f6f4df1e21dfa6x620x473.JPEG\" alt=\"Explanation Image\"><hr><h3>Related Pearl: Arsenic poisoning</h3><p>Summary of Arsenic poisoning</p>\n<p><strong>Source of exposure</strong>:&nbsp;Arsenic-containing pesticides, natural sources - drinking water and soil</p>\n<p><strong>Route of absorption</strong>:&nbsp;GI tract</p>\n<p><strong>Mechanism of action</strong>:&nbsp;binds to sulfhydryl groups and inhibits pyruvate dehydrogenase, gluconeogenesis, glutathione metabolism</p>\n<p>Characteristic clinical findings are as follows: Mnemonic-ARSENIC</p>\n<p><strong>A-&nbsp;</strong>Aldrich mees lines</p>\n<p><strong>R-&nbsp;</strong>raindrop pigmentation, rash,&nbsp;red velvety mucosa</p>\n<p><strong>S-&nbsp;</strong>subendocardial haemorrhage</p>\n<p><strong>E-&nbsp;</strong>Excessive pigmentation- Blackfoot&nbsp;disease</p>\n<p><strong>N-&nbsp;</strong>Neuritis</p>\n<p><strong>I-&nbsp;</strong>Iron oxide + BAL &ndash;treatment</p>\n<p><strong>C-&nbsp;</strong>Cholera like illness</p>\n<p><strong>Diagnosis</strong>:&nbsp;24-hour urine arsenic</p>\n<p><strong>Treatment</strong>:&nbsp;BAL; succimer(DMSA)</p>\n<p>Clinicopathological findings in acute and chronic arsenic poisoning:</p>\n<table>\n<tbody>\n<tr>\n<td>\n<p><strong>System</strong></p>\n</td>\n<td>\n<p><strong>Acute</strong></p>\n</td>\n<td>\n<p><strong>Chronic</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Skin</p>\n</td>\n<td>\n<p>Delayed hair loss (alopecia)</p>\n</td>\n<td>\n<p>Melanosis, Bowen&rsquo;s disease facial edema, hyperkeratosis, cutaneous cancer, hyperpigmentation.</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Nails</p>\n</td>\n<td>\n<p>Mees&rsquo;s lines in 2-3 weeks post ingestion.</p>\n</td>\n<td>\n<p><strong>Mees' lines</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Neurologic</p>\n</td>\n<td>\n<p>Hyperpyrexia, convulsions, tremors, coma</p>\n</td>\n<td>\n<p>Encephalopathy, polyneuropathy, tremors, axonal degeneration</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>GI tract</p>\n</td>\n<td>\n<p>Abdominal pain, dysphagia, vomiting, bloody or rice water diarrhea, mucosal erosions.</p>\n</td>\n<td>\n<p>Nausea, vomiting, diarrhea, anorexia, weight loss</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Liver</p>\n</td>\n<td>\n<p>Fatty infiltration</p>\n</td>\n<td>\n<p>Hepatomegaly, jaundice, cirrhosis</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Kidney</p>\n</td>\n<td>\n<p>Tubular and glomerular changes &ndash; oliguria and uremia</p>\n</td>\n<td>\n<p>Nephritic finding</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Haemetologic</p>\n</td>\n<td>\n<p>thrombocytopenia, impaired folate metabolism</p>\n</td>\n<td>\n<p>Bone marrow hypoplasia, anemia, leukopenia, basophilic stippling, and karyorrhexis.</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Cardiovascular</p>\n</td>\n<td>\n<ul>\n<li>S-T wave abnormalities,</li>\n<li>prolonged QT interval</li>\n<li>ventricular fibrillation</li>\n<li>atypical ventricular tachycardia&nbsp;</li>\n</ul>\n</td>\n<td>\n<p>There is platelet activation and hypercoagulability of blood in peripheral arteries leading to blackfoot disease</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Reproductive system</p>\n</td>\n<td>\n<p>Maternal ingestion of inorganic</p>\n<p>Arsenic crosses the placental barrier and infant death shortly after birth.</p>\n</td>\n<td>\n<p>-Nil-</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div><hr><h3>Related Pearl: Mercury Poisoning</h3><table>\n<tbody>\n<tr>\n<td>Features</td>\n<td>\n<p>Mercury</p>\n</td>\n</tr>\n<tr>\n<td>Source of exposure</td>\n<td>\n<p>Thermometers (elemental mercury)</p>\n<p>Industries (inorganic mercury)</p>\n<p>Fish (organic mercury) </p>\n</td>\n</tr>\n<tr>\n<td>Route of absorption</td>\n<td>\n<p>Elemental - Respiratory tract (negligible through GI unless the mucosa is damaged) </p>\n<p>Inorganic - GI tract</p>\n<p>Organic - GI tract</p>\n</td>\n</tr>\n<tr>\n<td>Mechanism of action</td>\n<td>\n<p>binds to sulhydryl groups of enzymes and affects</p>\n<ul>\n<li>glutathione metabolism</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>Organs affected (acute toxicity)</td>\n<td>\n<p>Respiratory tract (elemental mercury)</p>\n<p>GI tract (inorganic mercury)</p>\n<p>Respiratory + GI tract (organic mercury)</p>\n</td>\n</tr>\n<tr>\n<td>Organs affected (chronic toxicity)</td>\n<td>\n<p>CNS, Renal (elemental mercury)</p>\n<p>Renal (inorganic mercury)</p>\n<p>CNS (organic mercury)</p>\n</td>\n</tr>\n<tr>\n<td>Characteristic clinical findings</td>\n<td>\n<p> </p>\n<p><strong>Mnemonic: MEATS</strong></p>\n<p><strong>M</strong> -</p>\n<ul>\n<li>Mercuria lentis</li>\n<li>Membranous colitis </li>\n<li>Minimata disease</li>\n<li>Membranous glomerulopathy</li>\n</ul>\n<p><strong>E-</strong>Erethism (personality disturbance, insomnia, and loss of memory)</p>\n<p><strong>A</strong>-Acrodynia (Pink disease)</p>\n<p><strong>T-</strong>Tremors (Coarse tremors) - Include Danbury tremors, hatter’s or Glass blower’s shakes</p>\n<p><strong>S-</strong>Salivation (excessive salivation)</p>\n</td>\n</tr>\n<tr>\n<td>Diagnosis</td>\n<td>Blood and/or 24 hour urine mercury level</td>\n</tr>\n<tr>\n<td>Treatment</td>\n<td>BAL; succimer(DMSA)</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div><hr><h3>Related Pearl: Lead Poisoning/Plumbism/Saturnism</h3><table>\n<tbody>\n<tr>\n<td colspan=\"2\"><strong>Lead Toxicity</strong></td>\n</tr>\n<tr>\n<td>Source of exposure</td>\n<td>\n<p>Occupational exposure</p>\n<p>Lead paint</p>\n</td>\n</tr>\n<tr>\n<td>Route of absorption</td>\n<td>\n<p>Children - GI tract</p>\n<p>Adults - Respiratory tract</p>\n</td>\n</tr>\n<tr>\n<td>Mechanism of action</td>\n<td>\n<ul>\n<li>Binds to sulfhydryl groups and inhibits\n<ul>\n<li>ALA dehydratase</li>\n<li>Ferrochelatase</li>\n</ul>\n</li>\n<li>Inhibits pyrimidine 5' nucleotidase</li>\n<li>Competes with <strong>calcium</strong></li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>Organs affected <strong>(acute</strong> toxicity)</td>\n<td>\n<p>GI tract, Bone marrow, Peripheral nerves</p>\n</td>\n</tr>\n<tr>\n<td>Organs affected <strong>(chronic</strong> toxicity)</td>\n<td>\n<p>CNS, Kidney</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Characteristic clinical findings</p>\n<p><strong>(ABCDEF)</strong></p>\n</td>\n<td>\n<p><strong>A - </strong>Anemia with basophilic stippling</p>\n<p><strong>B - </strong>Burtonian line (blue stippled line on gums)</p>\n<p><strong>C - </strong>Constipation and colic (abdominal pain)</p>\n<p><strong>D - </strong>Drop (wrist and foot drop) due to neuropathy</p>\n<p><strong>E - </strong>Encephalopathy- <strong>Mostly seen in infants</strong> presenting with severe ataxia, vomiting, lethargy, stupor, convulsions, and coma</p>\n<p><strong>F - Facial pallor (Earliest sign)</strong></p>\n</td>\n</tr>\n<tr>\n<td>Diagnosis</td>\n<td>Blood lead levels</td>\n</tr>\n<tr>\n<td>Treatment</td>\n<td>Calcium EDTA; succimer(DMSA)</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/fcc02fa236a4485f90d2d484245ac27d.JPEG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MD2952",
      "difficulty": "medium"
    },
    {
      "text": "A 33-year-old lady comes for a routine check-up at 34 weeks of gestation when her blood pressure is found to be 170/118 mmHg. Her urine analysis shows proteinuria 3+. Which of the following statements are true about the management of this situation?<div class='question-desc-html'><ol>\n<li>Oral Captopril can be used as a second-line drug.</li>\n<li>Labetalol is safe in asthmatics and cardiac failure patients.</li>\n<li>The maximum dose of labetalol that can be given is 300 mg.</li>\n<li>Intravenous labetalol is the drug of choice.</li>\n<li>Sodium nitroprusside is the first-line drug.</li>\n</ol></div>",
      "choices": [
        {
          "id": 1,
          "text": "3 and 4 only"
        },
        {
          "id": 2,
          "text": "3 and 5 only"
        },
        {
          "id": 3,
          "text": "1, 2 and 5"
        },
        {
          "id": 4,
          "text": "1, 2, 4"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>The given clinical scenario is suggestive of severe&nbsp;<strong>pre-eclampsia</strong>&nbsp;with&nbsp;<strong>hypertensive crisis&nbsp;</strong>(BP&gt;160/110 mmHg)<strong>. Intravenous Labetalol&nbsp;</strong>is the drug of choice for controlling blood pressure in<strong> severe pre-eclampsia </strong>and the<strong> maximum dose</strong> that can be given is<strong> 300 mg</strong>. Therefore, options 3 and 4 are correct.&nbsp;</p>\n<p>Drugs used in the management of hypertensive crisis.</p>\n<table>\n<tbody>\n<tr>\n<td><strong>Drug</strong></td>\n<td><strong>Onset of Action&nbsp;</strong></td>\n<td><strong>Dose schedule&nbsp;</strong></td>\n<td><strong>Maximum dose&nbsp;</strong></td>\n<td><strong>Maintainance Dose&nbsp;</strong></td>\n</tr>\n<tr>\n<td><strong>Labetalol</strong></td>\n<td>5 mins</td>\n<td>10-20 mg IV every 10 mins&nbsp;</td>\n<td>300 mg IV</td>\n<td>40 mg/hr</td>\n</tr>\n<tr>\n<td><strong>Hydralazine</strong></td>\n<td>10 mins</td>\n<td>5 mg IV every 30 mins&nbsp;</td>\n<td>30 mg IV</td>\n<td>10 mg/hr</td>\n</tr>\n<tr>\n<td><strong>Nifedipine</strong></td>\n<td>10 mins&nbsp;</td>\n<td>10-20 mg oral, can be repeated in 30 mins&nbsp;</td>\n<td>240 mg/24 hours&nbsp;</td>\n<td>4-6 hour intervals&nbsp;</td>\n</tr>\n<tr>\n<td><strong>Nitroglycerin</strong></td>\n<td>0.5-5mins&nbsp;</td>\n<td>5 mcg/min IV</td>\n<td>Short-term therapy when other drugs failed</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td><strong>Sodium Nitroprusside&nbsp;</strong></td>\n<td>0.5-5mins&nbsp;</td>\n<td>0.25-5 mcg/kg/min IV</td>\n<td>Short-term therapy <strong>when other drugs failed</strong></td>\n<td>&nbsp;</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p class=\"p1\">&nbsp;</p>\n<p class=\"p1\">Captopril is an ACE inhibitor and is hence contraindicated in pregnancy.</p>\n<p class=\"p1\">Labetalol is avoided in women having asthma or cardiac failure.</p>\n<p class=\"p1\">Sodium nitroprusside is only given after treatment with other drugs has failed.&nbsp;</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "ME2021",
      "difficulty": "easy"
    },
    {
      "text": "A 7-year-old boy presents with dyspnea on exertion and bluish discoloration of lips, which is relieved on squatting. A chest x-ray is taken and is shown below. Which of the following is the primary defect responsible for this condition?",
      "choices": [
        {
          "id": 1,
          "text": "Anterior deviation of the infundibular septum"
        },
        {
          "id": 2,
          "text": "Pulmonary venous connection to the SVC"
        },
        {
          "id": 3,
          "text": "Downward displacement of tricuspid valve"
        },
        {
          "id": 4,
          "text": "Ostium secundum defect in the fossa ovalis"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>The clinical vignette showing <strong>cyanotic spells</strong> and chest x-ray showing a <strong>boot-shaped</strong> cardiac silhouette are suggestive of the<strong> Tetralogy of Fallot</strong>. The primary defect is an <strong>anterior deviation of the infundibular septum</strong> (the muscular septum that separates the aortic and pulmonary outflows).</p>\n<p><strong>Tetralogy of Fallot (TOF)</strong>&nbsp;is a&nbsp;cyanotic congenital heart condition&nbsp;and has been classically characterized by the following&nbsp;components:</p>\n<ul>\n<li>Obstruction to right ventricular outflow (<strong>pulmonary stenosis</strong>)</li>\n<li>Malalignment type of ventricular septal defect (<strong>VSD</strong>)</li>\n<li>Dextroposition of the aorta so that it overrides the ventricular septum (<strong>overriding of the aorta</strong>), and</li>\n<li>Right ventricular hypertrophy (<strong>RVH</strong>)</li>\n</ul>\n<p><strong>Paroxysmal hypercyanotic attacks</strong> (hypoxic, &ldquo;blue,&rdquo; or &ldquo;tet&rdquo; spells) are a problem during the 1st year of life and&nbsp;may last from a few minutes to a few hours. The child can have&nbsp;shortness of breath and bluish discoloration of lips which is relieved on squatting. Short episodes are followed by generalized weakness and sleep. Severe spells may progress to unconsciousness and occasionally to convulsions or hemiparesis.</p>\n<p>Older children with tetralogy of Fallot characteristically<strong> increase pulmonary blood flow</strong> by <strong>squatting</strong>.&nbsp;Squatting&nbsp;is a compensatory mechanism, it increases&nbsp;<strong>peripheral vascular resistance (PVR)</strong>&nbsp;and thus decreases the magnitude of the right-to-left shunt across the&nbsp;<strong>ventricular septal defect (VSD)</strong>.</p>\n<p>Chest X-ray describes \"<strong>Coeur en sabot</strong>\" or&nbsp;<strong>boot-shaped heart</strong>, which is seen in the&nbsp;tetralogy of Fallot (TOF).</p>\n<ul>\n<li>\"Coeur en sabot\" is due to cardiac apex elevation as a result of&nbsp;<strong>right ventricular hypertrophy.&nbsp;</strong>The cardiac silhouette has been likened to that of a boot.</li>\n<li>The hilar areas and lung fields are relatively clear because of&nbsp;<strong>diminished pulmonary blood flow</strong>&nbsp;or the small size of the pulmonary arteries.</li>\n<li>The aorta is usually large.</li>\n</ul>\n<p>Other options:</p>\n<p>Option B - A <strong>pulmonary venous connection to the superior vena cava (SVC)</strong> is seen in <strong>total anomalous&nbsp;pulmonary venous return</strong> (TAPVR). It is a cyanotic congenital heart defect in which the pulmonary veins drain directly into the right atrium, coronary sinus, SVC, IVC, or ductus venosus.</p>\n<p>On chest x-ray, supracardiac TAPVR presents with the <strong>snowman appearance of the heart&nbsp;</strong>which is as shown below</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/ce23f3a34ed842c08b637cf171dfe1d8x720x893.PNG\" alt=\"Explanation Image\"><p>Option C - A <strong>downward displacement</strong> of an <strong>abnormal tricuspid valve</strong>&nbsp;is seen in&nbsp;<strong>Ebstein</strong> <strong>anomaly</strong>, a cyanotic heart disease. Infants with severe disease present with marked cyanosis, massive cardiomegaly, and long holosystolic murmurs. Death may result from cardiac failure, hypoxemia, and pulmonary hypoplasia.&nbsp;</p>\n<p>Chest x-ray shows cardiomegaly caused by enlargement of the right atrium giving rise to a massive <strong>box-shaped cardiac</strong> shadow as shown below.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/a62677468177448caa2014bbfdf39028x625x549.PNG\" alt=\"Explanation Image\"><p>Option D - An <strong>ostium secondum defect</strong> in the <strong>fossa ovalis</strong> is the most common site of <strong>atrial septal defects</strong> (ASD). ASDs are abnormal, fixed openings in the atrial septum causing a&nbsp;<strong><span data-preserver-spaces=\"true\">left-to-right shunt.</span></strong></p>\n<p><span data-preserver-spaces=\"true\">Most ASDs are asymptomatic and are picked up during routine physical examinations. A widely fixed and split S2 is characteristic. A soft ejection systolic murmur best heard over the left upper sternal border is also commonly found.&nbsp;A mild left precordial bulge and a right ventricular systolic lift may be palpable at the left sternal border. Sometimes, a pulmonic ejection click can be heard.</span></p><hr><h3>Related Pearl: Radiological findings in some congenital heart defects</h3><p><strong>Boot shaped heart - Tetralogy of Fallot (TOF)</strong></p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/b8d455f894f24e8e9c147e7c3a178428x510x558.GIF\" alt=\"Pearl Image\"><p>&nbsp;</p>\n<p><strong>Egg on string appearance - Transposition of Great Arteries (TGA)</strong></p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/ad3fe6b6422548c8856299317c3e47c5x510x522.GIF\" alt=\"Pearl Image\"><p>&nbsp;</p>\n<p><strong>Snowman's heart appearance or figure of 8 appearance</strong> -&nbsp;<strong>Supracardiac TAPVC</strong></p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/c4d273d1af7445fdad02e659555c9e69x510x494.GIF\" alt=\"Pearl Image\"><p>&nbsp;</p>\n<p><strong>Box Shaped Heart - Ebstein's Anomaly</strong></p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/d07d5041004645849e8cce1dd37bd092x510x640.GIF\" alt=\"Pearl Image\">",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/dbd50778463e4fd3b998c78dd00b373b.JPEG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF1070",
      "difficulty": "medium"
    },
    {
      "text": "A 30-year-old man presented to the emergency department after suffering a penetrating injury to the neck. On examination, there is a small laceration just above the cricoid cartilage. His vitals were found to be stable. Examination revealed active bleeding from the site of injury. What is the next step of management?",
      "choices": [
        {
          "id": 1,
          "text": "Immediate neck exploration"
        },
        {
          "id": 2,
          "text": "CT Angiogram"
        },
        {
          "id": 3,
          "text": "Angioembolization"
        },
        {
          "id": 4,
          "text": "Bronchoscopy"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>The above clinical scenario of <strong>penetrating neck injury</strong> just above the <strong>cricoid cartilage</strong> corresponds to<strong> zone II</strong> neck injury. Although the patient is hemodynamically stable, the <strong>presence</strong> of <strong>hard signs</strong> such as <strong>active bleeding </strong>warrants<strong> immediate neck exploration</strong> as the next step of management.</p>\n<p><strong>Neck trauma</strong> is classified based on the different regions of the neck:</p>\n<ul>\n<li>Zone I: <strong>thoracic inlet </strong>to<strong> cricoid</strong>, associated with <strong>maximum mortality.</strong> It contains large vascular structures as well as the trachea and oesophagus.</li>\n<li>Zone II: <strong>cricoid cartilage</strong> to the <strong>angle of the mandible</strong>, <strong>most commonly prone to injury</strong> and most <strong>easily accessible</strong> for surgery. It contains the carotid and vertebral arteries, jugular veins, and structures of the aerodigestive tract.</li>\n<li>Zone III: <strong>angle of the mandible</strong> to the <strong>base of the skull</strong>. Structures within zone III include blood vessels that are <strong>difficult to expose</strong> surgically.</li>\n</ul>\n<p>The following are the <strong>indications</strong> for <strong>immediate surgical exploration</strong> of neck trauma. They are also known as the <strong>hard signs of neck trauma</strong>:</p>\n<ul>\n<li aria-level=\"1\"><strong>Active bleeding</strong> </li>\n<li aria-level=\"1\">Expanding or pulsatile hematoma</li>\n<li aria-level=\"1\">Air bubbling from penetrating injury</li>\n<li aria-level=\"1\">Massive subcutaneous emphysema</li>\n<li aria-level=\"1\">Hematemesis</li>\n<li aria-level=\"1\">Presence of neurological deficit</li>\n<li aria-level=\"1\">Fluid-resistant hemorrhagic shock</li>\n<li aria-level=\"1\">Audible bruit or palpable thrill</li>\n<li aria-level=\"1\">Airway compromise</li>\n</ul>\n<p>Management:</p>\n<ul>\n<li aria-level=\"1\"> If the patient is <strong>hemodynamically</strong> <strong>unstable </strong>or presence of any<strong> hard signs -</strong> <strong>neck exploration.</strong></li>\n<li aria-level=\"1\"> If the patient is stable- angiography and angioembolization are indicated. If it fails, then neck exploration should be done.</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF4828",
      "difficulty": "hard"
    },
    {
      "text": "A young girl presented with an inability to abduct her right thumb following a supracondylar fracture of her right humerus. The following test was done on her and found to be positive. What is the nerve likely to be injured?",
      "choices": [
        {
          "id": 1,
          "text": "Median nerve"
        },
        {
          "id": 2,
          "text": "Radial nerve"
        },
        {
          "id": 3,
          "text": "Ulnar nerve"
        },
        {
          "id": 4,
          "text": "Posterior interosseus nerve"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>The given clinical scenario and the image showing a <strong>positive pen test</strong> are suggestive of the weakness of the&nbsp;<strong>abductor pollicis brevis</strong> muscle. The nerve likely to be injured in this case is the&nbsp;<strong>median nerve</strong>.</p>\n<p>To perform the&nbsp;<strong>pen test</strong>, the hand is held flat with the palm facing upwards. A pen is held above the palm and the patient is asked to touch the pen with his thumb. If the patient is<strong> unable</strong> to<strong> touch</strong> the pen, it signifies a <strong>positive</strong> <strong>pen test</strong>.</p>\n<div class=\"ng-scope\">\n<div class=\"ng-scope\">\n<p>Median nerve lesions can be high lesions or low lesions depending on the site of injury.</p>\n<p><strong>Low lesions</strong>&nbsp;occur due to injuries at the <strong>distal 1/3<sup>rd </sup></strong>of the <strong>forearm</strong> such as carpal dislocation or cut wound of the wrist. There will be paralysis of the <strong>hand muscles</strong> and the patient will be <strong>unable</strong> to <strong>abduct</strong> the <strong>thumb</strong>. There is also a <strong>loss </strong>of <strong>sensation</strong> over the <strong>radial 3&frac12;&nbsp;digits</strong>. The&nbsp;<strong>forearm muscles</strong>&nbsp;supplied by the median nerve&nbsp;are<strong> spared</strong>&nbsp;in these lesions. Wasting of thenar eminence is seen in long-standing cases.</p>\n<p><strong>High lesions</strong>&nbsp;occur due to injuries&nbsp;<strong>above</strong> the<strong> elbow</strong>&nbsp;such as&nbsp;<strong>forearm fractures </strong>or<strong> elbow dislocation</strong>. There is <strong>paralysis</strong> of the <strong>forearm muscles</strong> along with all the features of low lesions.</p>\n<p>Muscles supplied by the median nerve are given in the table:</p>\n<table>\n<tbody>\n<tr>\n<td>In the arm</td>\n<td>No muscles</td>\n</tr>\n<tr>\n<td>Proximal 1/3<sup>rd</sup> of the forearm</td>\n<td>All the flexor muscles of the proximal forearm, except the flexor carpi ulnaris and the medial half of the flexor digitorum profundus</td>\n</tr>\n<tr>\n<td>Distal 1/3<sup>rd</sup> of the forearm&nbsp;</td>\n<td>No muscles</td>\n</tr>\n<tr>\n<td>In the hand</td>\n<td>\n<p><strong>Abductor pollicis brevis<br /></strong>Opponens pollicis<br />Flexor pollicis brevis<br />First two lumbricals</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>Other tests for median nerve:&nbsp;</p>\n<p><strong>Pointing index sign</strong> or <strong>Oschner&rsquo;s clasp test </strong>- the patient is asked to clasp both hands together. When this is done the index&nbsp;and the middle finger fail to flex due to the loss of action of long finger flexors which are supplied by the median nerve.&nbsp;</p>\n<p><strong>Benediction test </strong>- due to loss of activity of the long finger flexors&nbsp;the patient is unable to flex the index and middle finger&nbsp;on lifting the hand. As this is the position a clergyman uses to bless the couple during the marriage, it is called&nbsp;the benediction test.</p>\n</div>\n</div><hr><h3>Related Pearl: Upper limb nerve integrity tests</h3><table>\n<tbody>\n<tr>\n<td>&nbsp;<strong>Nerve</strong></td>\n<td>\n<p>&nbsp; <strong>&nbsp; Test</strong></p>\n</td>\n<td>\n<p>&nbsp; &nbsp;<strong> Muscle</strong></p>\n</td>\n</tr>\n<tr>\n<td>&nbsp;Ulnar&nbsp; &nbsp;nerve</td>\n<td>\n<p>&nbsp;1.Book test</p>\n<p>&nbsp;2.Card test</p>\n<p>&nbsp;3.Froment's sign</p>\n<p>&nbsp;4.Egawa test</p>\n</td>\n<td>\n<p>&nbsp;1.Adductor&nbsp; &nbsp;pollicis</p>\n<p>&nbsp;2.Palmar&nbsp; &nbsp;interossei</p>\n<p>&nbsp;3.Flexor pollicis&nbsp; &nbsp;substitutes for&nbsp; &nbsp;adductor pollicis</p>\n<p>&nbsp;4.Dorsal&nbsp; &nbsp;interossei</p>\n</td>\n</tr>\n<tr>\n<td>&nbsp;Median&nbsp; &nbsp;nerve</td>\n<td>\n<p>&nbsp;1.Ape thumb</p>\n<p>&nbsp;2.Pen test</p>\n<p>&nbsp;3.Pincer grasp&nbsp; &nbsp;(Kiloh Nevin&nbsp; &nbsp;Sign)</p>\n<p>&nbsp;4.Pointing index&nbsp; &nbsp;(ochners&nbsp; clasp/Benediction&nbsp; &nbsp;test)</p>\n</td>\n<td>\n<p>&nbsp;1.Thenar&nbsp; &nbsp;muscles</p>\n<p>&nbsp;2. Abductor&nbsp; &nbsp;pollicis brevis</p>\n<p>&nbsp;3. Flexor&nbsp; &nbsp;digitorum&nbsp; &nbsp;profundus+&nbsp; &nbsp;Flexor pollicis&nbsp; &nbsp;longus (Ant.&nbsp; &nbsp;interosseous&nbsp; &nbsp;nerve)</p>\n<p>&nbsp;4.Flexor&nbsp; &nbsp;Digitorum&nbsp; &nbsp;superficialis+&nbsp; &nbsp;Lateral half of&nbsp; &nbsp;Flexor&nbsp; &nbsp;digitorum&nbsp; &nbsp;profundus</p>\n</td>\n</tr>\n<tr>\n<td>&nbsp;Radial&nbsp; &nbsp;nerve</td>\n<td>\n<p>&nbsp;1.Thumb and&nbsp; &nbsp;finger drop</p>\n<p>&nbsp;2. Wrist drop</p>\n</td>\n<td>\n<p>&nbsp;1.Extensors(Post.&nbsp; &nbsp;interosseous&nbsp; &nbsp;nerve)</p>\n<p>&nbsp;2.Extensors of&nbsp; &nbsp;wrist.</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/a5f6ce3454034878a803f4d2a05803ec.PNG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF6616",
      "difficulty": "medium"
    },
    {
      "text": "A 3-year-old girl is being evaluated for congenital ptosis. On examination, there is retraction of the ptotic lid when she is asked to move her jaw from side to side. It is inferred that there is a misdirection of the nerve supplying the jaw muscles to the levator palpebrae muscle. Identify the misdirected nerve.",
      "choices": [
        {
          "id": 1,
          "text": "1"
        },
        {
          "id": 2,
          "text": "2"
        },
        {
          "id": 3,
          "text": "3"
        },
        {
          "id": 4,
          "text": "4"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>The given clinical scenario describes <strong>Marcus&ndash;Gunn jaw-winking syndrome</strong>. The misdirected cranial nerve supplying the jaw muscles is the mandibular division of the <strong>trigeminal nerve</strong>&nbsp;labeled as '4'.</p>\n<p><strong>Trigeminal nerve</strong></p>\n<p>The trigeminal nerve leaves the <strong>anterior aspect of the pons</strong> as a small motor root and a large sensory root. The nerve passes forward out of the posterior cranial fossa and rests on the upper surface of the apex of the <strong>petrous part of the temporal bone</strong> in the middle cranial fossa. The large sensory root now expands to form the crescent-shaped <strong>trigeminal ganglion</strong>, which lies within a pouch of dura mater called the trigeminal or Meckel cave. The ophthalmic, maxillary, and mandibular nerves arise from the anterior border of the ganglion.</p>\n<p><strong>Branches of the trigeminal nerve</strong></p>\n<ul>\n<li><strong>The ophthalmic nerve (V1)</strong>\n<ul>\n<li>Leaves the skull through the<strong> superior orbital fissure</strong> to enter the orbital cavity.</li>\n<li>Contains only <strong>sensory</strong> fibers\n<ul>\n<li>Cornea</li>\n<li>Skin of forehead, scalp, eyelids, and nose</li>\n<li>Mucous membrane of paranasal sinuses and nasal cavity</li>\n</ul>\n</li>\n</ul>\n</li>\n<li><strong>The maxillary nerve (V2)</strong>\n<ul>\n<li>Leaves the skull through the <strong>foramen rotundum.</strong></li>\n<li>Contains only <strong>sensory</strong> fibers from\n<ul>\n<li>Teeth of upper jaw</li>\n<li>Skin of face over maxilla</li>\n<li>Mucous membrane of nose, the maxillary sinus, and palate</li>\n</ul>\n</li>\n</ul>\n</li>\n<li><strong>The mandibular nerve (V3</strong>)\n<ul>\n<li>Leaves the skull through the <strong>foramen ovale.</strong></li>\n<li>Contains both sensory and motor fibers.</li>\n<li><strong>Sensory</strong> from\n<ul>\n<li>Skin&nbsp;of&nbsp;cheek, over mandible and side&nbsp;of&nbsp;head</li>\n<li>Teeth&nbsp;of&nbsp;lower jaw and temporomandibular joint</li>\n<li>Mucous membrane&nbsp;of&nbsp;mouth and anterior part&nbsp;of&nbsp;tongue</li>\n</ul>\n</li>\n<li><strong>Motor</strong> to\n<ul>\n<li>Muscles of mastication (pterygoids, masseter and temporalis)</li>\n<li>Tensor tympani</li>\n<li>Anterior belly of digastric</li>\n<li>Mylohyoid</li>\n</ul>\n</li>\n</ul>\n</li>\n</ul>\n<p><strong>Marcus&ndash;Gunn jaw-winking syndrome:</strong></p>\n<ul>\n<li>About <strong>5%</strong> of all cases of <strong>congenital ptosis</strong> are associated with the Marcus&ndash;Gunn jaw-winking phenomenon.</li>\n<li>The vast majority are <strong>unilateral</strong>.</li>\n<li><strong>Etiology</strong>:<strong>&nbsp;</strong>a branch of the <strong>mandibular division</strong> of the <strong>fifth</strong> cranial nerve is <strong>misdirected</strong> to the levator muscle.</li>\n<li>Signs\n<ul>\n<li><strong>Retraction of the ptotic lid</strong> in conjunction with <strong>stimulation of the ipsilateral pterygoid muscles</strong> by <strong>chewing</strong>, <strong>sucking</strong>, opening the mouth, or contralateral jaw movement.</li>\n<li>Less common stimuli to winking include <strong>jaw protrusion</strong>, <strong>smiling</strong>, swallowing, and clenching of teeth.</li>\n<li><strong>Jaw-winking does not improve with age</strong> although patients may learn to mask it.</li>\n</ul>\n</li>\n</ul>\n<p><strong>Image</strong>:&nbsp;The woman cannot control her eyelids while drinking.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/7dee4f8a38f34d9bae43f489f12a0038x466x313.PNG\" alt=\"Explanation Image\"><p><strong>Image</strong>: showing the anterior surface of pons and the cranial nerves.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/b18ce187f0c248829301610677f51205x1280x1444.JPEG\" alt=\"Explanation Image\"><hr><h3>Related Pearl: Structures passing through skull foramina</h3><table>\n<tbody>\n<tr>\n<td><strong>Opening</strong></td>\n<td><strong>Transmits</strong></td>\n</tr>\n<tr>\n<td><strong>Optic canal</strong></td>\n<td>\n<ul>\n<li>Optic nerves</li>\n<li>Ophthalmic arteries</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td><strong>Superior orbital fissure</strong></td>\n<td>\n<ul>\n<li>Lacrimal nerve (V1)</li>\n<li>Frontal nerve (V1)</li>\n<li>Nasociliary nerve (V1)</li>\n<li>CNs III, IV, VI</li>\n<li>Superior ophthalmic vein</li>\n<li>Inferior ophthalmic vein</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td><strong>Foramen rotundum</strong></td>\n<td>\n<ul>\n<li>Maxillary division of CN V (V2)</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td><strong>Foramen ovale</strong></td>\n<td>\n<ul>\n<li><strong>M</strong>andibular division of CN V (V3)</li>\n<li><strong>A</strong>ccessory meningeal artery</li>\n<li><strong>L</strong>esser petrosal nerve</li>\n<li><strong>E</strong>missary veins</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td><strong>Foramen spinosum</strong></td>\n<td>\n<ul>\n<li>Middle meningeal artery</li>\n<li>Nervus spinosus</li>\n<li>Middle meningeal vein</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td><strong>Foramen lacerum</strong></td>\n<td>\n<ul>\n<li>Deep petrosal nerve</li>\n<li>Meningeal branch of ascending pharyngeal artery&nbsp;</li>\n<li>Emissary vein</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td><strong>Carotid canal</strong></td>\n<td>\n<ul>\n<li>Internal carotid artery</li>\n<li>Venous and sympathetic plexus around artery</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td><strong>Jugular foramen</strong></td>\n<td>\n<ul>\n<li>Inferior petrosal sinus</li>\n<li>Meningeal branch of ascending pharyngeal artery&nbsp;</li>\n<li>CNs IX,X &amp; XI</li>\n<li>Sigmoid Sinus continuing as IJV&nbsp;</li>\n<li>Middle meningeal branch of occipital artery</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td><strong>Hypoglossal canal</strong></td>\n<td>\n<ul>\n<li>Hypoglossal nerve (CN XII)</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td><strong>Foramen magnum</strong></td>\n<td>\n<div class=\"ng-scope\">\n<div class=\"ng-scope\">\n<ul>\n<li class=\"ng-binding\">Osseo-ligamentous (anterior) compartment:&nbsp;\n<ul>\n<li>Apical ligament and tip of dens</li>\n<li>Upper band of cruciate ligament</li>\n<li>Membrana tectoria</li>\n</ul>\n</li>\n<li>Neuro-vascular (posterior)&nbsp;compartment:\n<ul>\n<li>Lower end of the medulla oblongata with meninges</li>\n<li>Fourth part of vertebral artery surrounded by sympathetic plexus of nerves</li>\n<li>Spinal roots of accessory nerves</li>\n<li>Anterior and posterior spinal arteries</li>\n<li>Tonsil of cerebellum.</li>\n</ul>\n</li>\n</ul>\n</div>\n</div>\n<div class=\"ng-scope\">&nbsp;</div>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>&nbsp;</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/59dee8c948d642d8b7e732620bd2e2a7x600x1522.JPEG\" alt=\"Pearl Image\">",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/8cebb4df089a4bc6a014898d3dfa63f7.JPEG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MD8533",
      "difficulty": "medium"
    }
  ]
}